




































































































coSled(participant( recruitment( for( this( second( stage( of( assessment( along(with(Hayley(Moulding.( I(
conducted(all( of( the(unusual( spell( interviews(described( in( this( thesis,( collected(all( of( the( relevant(
medical(records,(administered(all(of(the(unusual(spells(diaries(and(collected(the(majority(of(the(data(
pertaining( to( a( family( history( of( seizures( and( epilepsy.( The( 24Shour( ambulatory( EEG( study( with(
deletion(carriers(and(control(siblings(was(conducted(in(the(family(home,(requiring(travel(to(different(










I( prepared( an( application( for( ethical( approval( of( the( pilot( 24Shour( EEG( study( with( children( and(
adolescents( from( the( general( population,( alongside(Hayley(Moulding.( I( conducted( all( of( the( EEG(
assessments(in(this(pilot(study(alongside(Hayley(Moulding(and(Dr(Ullrich(Bartsch((
Data( relating( to( cognition,(psychiatric(disorders,( sleep(disturbance,( autism( spectrum(disorder( and(
motor(coordination(problems(were(collected(primarily(by(the(ECHO(study(field(team.(I(conducted(nine(
( iv(
of( the(psychiatric( interviews(and(assigned(diagnoses.( I(conducted(all(of( the(analyses( in( this( thesis((
involving(the(cognitive,(psychiatric(and(other(neurodevelopmental(data(and(interpreted(the(results.(
All( of( the( research(presented( in( this( thesis(was( conducted(under( the(guidance(of(my( supervisors,(
Professor( Marianne( van( den( Bree,( Professor( David( Linden( and( Professor( Michael( Owen( (Cardiff(
University).((
The(manuscript(based(on(the(analyses(from(Chapter(4(and(5(of(this(thesis(was(written(by(myself,(under(
the( guidance( of(my( supervisors( and(Dr( Khalid( Hamandi,( Dr( Rhys( Thomas,( Dr( Adam(Cunningham,(


























diagnoses( were( confirmed.( One( deletion( carrier( was( newly( diagnosed( with( epilepsy.( Only( 11.8%(
reported( with( an( afebrile( seizure( or( paroxysmal( event( were( diagnosed( with( epileptic( seizures(
(‘possible’(absence(seizures).((
These( findings( reinforce( that( young( people( with( 22q11.2DS( are( at( increased( risk( for( acute(
symptomatic(seizures((predominantly(febrile(seizures)(and(epilepsy.(I(also(provide(evidence(to(suggest(









































































































































































































Table( 5S3.( The( percentage( of( ESQSreported( epilepsy,( febrile( seizures( and( afebrile( seizures( or(
paroxysmal(events(that(were(confirmed(by(the(epileptologist(after(review(of(the(data(from(the(second(
stage(of(assessment.(.....................................................................................................................(114(





Table(5S8.(Details( of( the( family(history(of( epileptic( seizures( and(epilepsy( in( six( young(people(with(
22q11.2DS.(....................................................................................................................................(128(
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rearrangement( of( 1000( base( pairs( (1( kilobase,( kb)( or( more.( CNVs( are( littered( throughout( an(
individual’s(genome(and(they(often(have(little(to(no(effect(on(development.(However,(some(CNVs(are(
pathogenic(and(disrupt(core(developmental(processes.(Such(pathogenic(CNVs(have(been(linked(with(
risk( for( medical( conditions( and( neuropsychiatric( disorders.( Examples( includes( deletions( and(
duplications( of( DNA( in( chromosome( 16p11.2,( which( have( been( associated( with( micro( and(









of( low(copy(repeats( (LCRs;(sections(of(DNA(that(share(>96%(of(sequence( identity)( in( the(22q11.2(
region,(increasing(the(probability(of(nonSallelic(homologous(recombination(during(meiosis12.(Figure(1S
1( provides( a( visual( overview( of( the( variety( of( typical( and( atypical( deletions( that( can( occur( on(
chromosome(22q11.2.(In(around(90%(of(people(with(22q11.2DS,(a(deletion(of(3(million(base(pairs(
(megabase,(Mb)(occurs(between( LCR22A(and( LCR22D,( the( two( largest(breakpoints( in( the(22q11.2(






























































Intact  copy of 
chromsome 22












majority( of( cases( the( ID( is( mild( (FSIQ=55S70),( less( commonly( moderate( (FSIQ=40S54)( and( rarely(
reaches( severe( levels( (FSIQ(<40)11,25,27,28.( Factors( associated(with(poorer( intellectual( functioning( in(
22q11.2DS(include(having(an(inherited(deletion11(and(neonatal(hypocalcaemia29.(The(22q11.2(deletion(
has(been(observed( in( ID/(developmental(delay( (DD)(cohorts(at(a( rate(of(between(0.61%S2.4%30,31;(
indeed,(it(is(the(second(most(common(cause(of(ID/DD((after(Down(syndrome.((
People(with(22q11.2DS(show(impairments(in(numerous(cognitive(domains.(Relative(deficits(in(nonS




having( difficulties(with(mathematics( but( demonstrating( relative( strengths( in( reading( and( spelling(
tasks,(although(some(patients(exhibit(difficulties(with(expressive(and(receptive(language24,32.(People(
with(22q11.2DS(also(have(impairments(in(neurocognitive(domains(such(as(spatial(working(memory,(











to( develop( psychotic( disorders36,40.( By( contrast,( other( longitudinal( assessments( have( found( no(
evidence(for(cognitive(deterioration(in(22q11.2DS41,42.(A(recent(study(from(our(group(showed(a(decline(
in(processing(speed,(attention,(spatial(planning(and(spatial(working(memory( in(young(people(with(
22q11.2DS(over( a( twoSandShalf( year(period.( This( is( one(of( very( few( studies( in(22q11.2DS( to(have(
included( a( control( sample( and( interestingly,( the( prevalence( of( deterioration( in( the( group( with(





symptoms,( in(which(an( individual( is( unable( to(differentiate(between( real( and(unreal( experiences.(
Examples(include(delusions(and(hallucinations.(Negative(symptoms(are(also(present(in(schizophrenia,(
which( are( characterised( by( a( loss( of( normal( functioning.( Examples( include( reduced( emotional(
expression(and(loss(of(motivation(and(interest.(Disorganised(symptoms(are(another(key(feature(of(the(
syndrome,(in(which(the(individual(exhibits(disordered(thoughts(and(behaviour44.(Schizophrenia(has(a(
typical( onset( in( late( adolescence(or( early( adulthood45,( but( in( rare( cases( can(be(diagnosed(during(
childhood46.(














The(presentation(of(schizophrenia( in(people(with(22q11.2DS( is(broadly(similar( to( that(observed( in(






22q11.2DS( and( schizophrenia( have( less( lifetime( substance( use( and( poorer( impulse( control,(
cooperativeness(and(greater(hostility(than(idiopathic(schizophrenia(patients56.(
1.4.2! Attention(deficit(hyperactivity(disorder(
ADHD( is( a( neurodevelopmental( disorder( characterised( by( symptoms( of( inattentiveness( and/or(




Inattentive( ADHD( is( characterised( by( poor( attentional( control( and( high( distractibility,(whereas( in(
hyperactiveSimpulsive(ADHD(the(patient(is(restless(and(has(difficulty(controlling(impulsive(behaviour.(
Individuals(presenting(with( a( combination(of( inattentive(and(hyperactiveSimpulsive( symptoms(are(





study( found( that( 37%( of( children( with( the( deletion( had( ADHD.( This( was( the( most( common(









crossSsectional26( and( longitudinal( studies63( in( 22q11.2DS( have( revealed( that( ADHD( persists( into(
adolescence(and(adulthood(in(22q11.2DS,(as(it(does(in(the(general(population.(Around(65%(of(children(




In( other( respects( the( presentation( of( ADHD( in( 22q11.2DS( differs( quite( substantially( from( that(
observed(in(idiopathic(ADHD.(Inattentive(ADHD(is(the(predominant(ADHD(subtype(in(22q11.2DS62,65(
(60%( in( the( 22q( IBBC( study26),( whereas( hyperactiveSimpulsive( and( combined( subtypes( are(more(
common( in( idiopathic( ADHD62,66.( In( particular,( deletion( carriers( show(more( inattentive( symptoms(
within( an( academic( context( than( children( with( idiopathic( ADHD( (likely( related( to( the(





are(not(explained(by(the(effects(of( intellectual(disability( in(22q11.2DS(or(by(the(differences( in( the(
prevalence(of(ADHD(subtypes(between(22q11.2DSSADHD(and(idiopathic(ADHD62.((









children( was( being( treated( for( ADHD( (stimulant( medication)62.( In( addition( to( a( caution( to( use(
stimulants( with( this( population( due( to( cardiac( problems,( a( lack( of( treatment( may( plausibly( be(
attributed( to( diagnostic( overshadowing( brought( about( by( the( complex( cognitive( and( psychiatric(





‘Anxiety( disorder’( is( an( umbrella( term( for( a( number( of( psychiatric( disorders,( all( of( which( are(
characterised(by(excessive(fear(and(worry(that(leads(to(behavioural(disturbances,(such(as(pervasive(
strategies( to( try( and( avoid( the( feared/anxietySinducing( situation44.( Anxiety( disorders( have( been(
estimated(to(affect(7%(of(people(worldwide68.(
People(with(22q11.2DS(commonly(experience(anxiety(and(many(are(diagnosed(with(anxiety(disorders.(
The(22q( IBBC( study( found( that( 31%(of(people(with(22q11.2DS(had(an(anxiety(disorder.(Of( these,(
around(a(third(met(criteria(for(two(or(more(anxiety(disorders.(The(prevalence(of(generalised(anxiety(
disorder((GAD)(and(obsessiveScompulsive(disorder((OCD)(appears(to(remain(stable(from(childhood(to(























Studies(have(estimated( that(between(14S50%(of( people(with(22q11.2DS( have(ASD27,60,74S76,( a( rate(
significantly(higher(than(in(their(unaffected(sibling(controls((5%)27.(These(studies(have(however(relied(
on(screening(tools(and/or(parentSreport(of(ASD(symptoms.(This(may(lead(to(inaccurate(estimates(of(
ASD( prevalence( in( 22q11.2DS,( because( there( is( a( notable( degree( of( symptom( overlap( between(
22q11.2DS(and(ASD.(For(example,(children(with(22q11.2DS(fixate(less(on(the(eyes(and(more(on(the(
mouth(during(emotion(processing(tasks77,(as(do(people(with(idiopathic(ASD78.(In(addition,(the(high(





without( ASD( have( a( broadly( similar( communication( profile81.( In( addition,( there( are( features( that(
distinguish(22q11.2DS(cases(with(and(without(ASD.(Children(with(22q11.2DS(and(ASD(are(reported(by(









diagnosed( with( ASD,( with( prevalence( peaking( during( adolescence( (27%).( However,( 72%( of( the(
adolescents( diagnosed( with( ASD( were( obtained( from( Utrecht,( a( site( which( only( used( the( ADISR,(
meaning(the(rate(of(ASD(during(adolescence(in(22q11.2DS(may(have(been(erroneously(inflated26.((
Finally,(there(are(some(differences(between(the(presentation(of(ASD(in(22q11.2DS(and(ASD(in(people(





leads( to( conflict( with( authority( figures( and( violation( of( societal( rules.( I( will( discuss( two( specific(
( 9(
disruptive(disorders(in(this(section.(Firstly,(oppositional(defiant(disorder((ODD)(is(defined(by(vindictive(
and( defiant( behaviour,( as( well( as( angry/irritable( mood.( Conduct( disorder( (CD)( is( a( more( severe(
disruptive(disorder(and(supersedes(a(diagnosis(of(ODD.(CD(is(characterised(by(behaviours(that(violate(
social( norms(and( the( rights(of(other(people( (e.g.(vandalism(of(property)44.(ODD(has( an(estimated(
prevalence(of(8%(in(adolescents((13S17(years(old)(from(the(general(population,(whilst(CD(is(thought(
to(be(diagnosed(in(5%84.(
Between(14S18%(of( children(and(adolescents(with(22q11.2DS(are(diagnosed(with(ODD26,27,( a( rate(
















OSA(after(surgery( to(correct( the(velopharyngeal( insufficiency(commonly(seen( in( this(syndrome,(as(










22q11.2DS( (81%)( screened( positive( for( developmental( coordination( disorder( (DCD)90.( DCD( is( a(
neurodevelopmental(disorder(characterised(by(impairments(fine(motor(skills,(gross(motor(skills,(or(



















(Cunningham( et( al.),( comparing( deletion( carriers( with( unaffected( sibling( controls,( volumetric(
reduction( of( bilateral( superior( parietal( areas( and( white( matter( abnormalities( in( the( left( inferior(
cerebellar(peduncle(did(not(significantly(associate(with(motor(coordination(scores99.( (Some(studies(
have(also(reported(a(reduction(in(the(volume(of(the(hippocampus(in(young(people(with(22q11.2DS,(
which( showed( a( negative( correlation(with( FSIQ( and( a( relationship(with( impaired( association( and(
recall100,101.( When( comparing( deletion( carriers( with( typically( developing( controls( however,( other(
studies( have( failed( to( observe( any( differences( in( hippocampal( volume36,102,103.( Young( people(with(
22q11.2DS(and(ASD(also(have(a(larger(right(amygdala(volume75,(a(structure(involved(in(rapid(emotional(
( 11(
processing104.( A( larger( right( amygdala( volume( has( been( associated( with( deficits( in( social(
communication(and(interaction(in(idiopathic(ASD(cases105.(
During( adulthood,( the( rostralScaudal( gradient( of( structural( abnormalities( disappears,( with( adult(
deletion(carriers(showing(volumetric(reductions(in(frontal(and(temporal(areas,(which(are(particularly(


































according( to( whether( they( feature( prominent(motor( features( (e.g.( generalised(motor/nonSmotor(
seizure)( and( in( the( case( of( focal( seizures( whether( they( result( in( impaired( awareness( (e.g.( focal(




Another( mode( of( classification( is( to( delineate( between( ‘acute( symptomatic’( and( ‘unprovoked’(
epileptic(seizures.(This(classification(system(is(important(because(it(highlights(the(subtle(distinction(
between( an( individual( experiencing( epileptic( seizures( and( an( individual( who( is( diagnosed( with(
epilepsy.(Acute(symptomatic(seizures(are(brought(about(acute(conditions.(For(example,(a(high(fever(






benign118.( Complex( febrile( seizures( affect( only( one( part( or( side( of( the( body,( or( are( abnormally(
prolonged,( lasting( 30( minutes( or( more( (also( known( as( ‘febrile( status( epilepticus’,( FSE).( ( They(














today,( people(with( epilepsy( experience( stigma.( In( particular,( the( intermittent,( often( spontaneous(




epilepsy110,126( and(who( could( advocate( for( better( understanding( and( treatment( of( this( condition.(














generating( epileptic( seizures).( There( is( a( great( deal( of(misunderstanding( amongst( the( public( and(
clinicians(alike(about(the(role(of(EEG(in(diagnosing(epilepsy(however;(it(is(strictly(an(adjunct(to(the(










may( be( particularly( salient( when( reading( the( EEG( trace( from( children( with( neurodevelopmental(
disorders.(The(process(of(diagnosing(epilepsy(is(made(more(difficult(through(the(numerous(conditions(
that(can(mimic(features(of(epileptic(seizures.(An(example(is(vasovagal(syncope,(in(which(an(individual(






Aetiology( is( of( paramount( importance( when( classifying( the( epilepsies,( informing( prognosis( and(
treatment( options110.The( most( recent( classification( system114( defines( the( ‘genetic( epilepsies’(
(previously(known(as(the(‘idiopathic(epilepsies’138)(as(those(with(a(known(or(presumed(genetic(cause.((





types.( These( are( known( as( electroclinical( syndromes.( They( have( a( strong( genetic( basis( and( are(
associated( with( certain( developmental( stages.( Examples( include( childhood( absence( epilepsy( and(
juvenile(myoclonic(epilepsy114.(
1.7.1.3! Comorbidities(
People( with( epilepsy( may( experience( numerous( comorbid( neurodevelopmental( and( psychiatric(
disorders.(Epilepsy(is(found(at(higher(rates(in(those(with(ID((14S44%),(particularly(those(with(more(
severe(forms(of(ID129,139.((
In( addition( to( this( deficit( in( global( intellectual( functioning,( people( with( epilepsy( show( deficits( in(









of( ASD( is( higher( in( epilepsy( than( in( other( chronic( neurologic( conditions( (e.g.(migraine)124.( ADHD(
prevalence( is( estimated( at( ~30%( in( epilepsy,( based( on( diagnoses( from( a( child( psychiatrist143.( In(
addition,(ADHD(symptoms(are(more(common(in(frontal(lobe(epilepsy,(CAE(and(Rolandic(epilepsy(and(
often(precede(seizure(onset144.(Conduct(disorders(are(diagnosed(in(13S24%(of(epilepsy(patients,(based(
on( data( from( semiSstructured( interviews,( the( data( from( which( was( reviewed( by( clinicians( and(










with( epilepsy,( sleep( disturbance( associates( with( poorer( cognition( and( behaviour( during( the(
daytime149.(
Finally,( children( with( epilepsy( also( often( present( with( comorbid(motor( problems.( A( study( of( 21(
children(and(adolescents(with(BECTS(observed(that(nearly(half((48%)(of(patients(exhibited(difficulties(
in( one( or( more( areas( of( motor( functioning,( such( as( manual( dexterity,( balance( and( aiming( and(
catching150.(
Comorbidities( between( epilepsy( and( impaired( cognition,( psychopathology,( sleep( disturbance( and(
motor(problems(suggest(shared(neurobiological(risk(pathways(for(these(conditions.(For(example,(both(
ASD(and(epilepsy(are(thought(to(be(the(result(of(aberrant(synaptic(plasticity,(leading(to(an(imbalance(
in( neuronal( excitationSinhibition.( However,( it( may( also( be( the( case( that( epileptic( seizures( have(





in( which( epileptic( activity( is( thought( to( contribute( to( the( severe( cognitive( and( behavioural(







neurological( mechanisms( that( are( independent( of( the( process( of( epileptogenesis.( For( example,(
prolonged( epileptic( activity( during( sleep(may( disrupt( slowSwave( activity( that( is( associated(with( a(








years( has( led( to( an( understanding( that( CNVs( contribute( to( the( genetic( aetiology( of( numerous(
epilepsies,( particularly( those(with( comorbid( dysmorphic( features,( intellectual( disability( or( ASD154.(




























impaired( awareness( and( focal( to( bilateral( tonicSclonic( seizures.( Neuroanatomical( abnormalities(
present( in( 22q11.2DS( that( can( confer( risk( for( epileptic( seizures( include( diffuse( cerebral( atrophy,(
polymicrogyria,( hippocampal( malrotation,( grey( and( white( matter( heterotopia( and( focal( cortical(
dysplasia.(However,(other(than(these(abnormalities,(there(is(a(dearth(of(research(into(biomarkers(for(
epilepsy(risk(in(22q11.2DS.(Whilst(focal(epilepsy(is(the(most(common(type(in(22q11.2DS((44%(of(those(




(A( specific( GGE( electroclinical( syndrome( that( the( 22q11.2( deletion(may( confer( risk( for( is( juvenile(
myoclonic(epilepsy((JME),(which(typically(onsets(in(adolescence(and(is(characterised(predominantly(







which( (GABBR1)( is( located( on( chromosome( 6p21.3166.( GABAB1Sdeficient(mice( exhibit( spontaneous(
epileptiform(discharges,(clonic,(tonicSclonic(and(atypical(absence(seizures172.#((
Little(is(known(about(how(often(individuals(with(22q11.2DS(have(epileptic(seizures.(Case(reports(have(






























record( review.( Differences( between( medical( centres( and( clinicians( in( diagnostic( methods( (e.g.(






subtle,( stereotyped( paroxysms( seem( to( lead( to( no( obvious( impairment( in( an( individual( with(
22q11.2DS,(their(caregivers(may(prioritise(time(with(clinicians(to(speak(about(other(conditions(that(





studies(do(not(specify( the(duration(of( the(EEG(recordings.( If( the(reported( findings(were(based(on(
routine,(interictal(clinical(EEG(((i.e.(~30(minutes),(then(epileptiform(discharges(may(have(been(missed(
in(some(cases,(for(example,(those(occurring(during(sleep.(
Finally,( whilst( studies( have( begun( to( address( the( links( of( seizures( and( epilepsy( with(





phenotype.(People(with(22q11.2DS(may(also(be(at( risk( for(acute(symptomatic(seizures( (e.g.( those(























2.! Better( characterise( the( aetiology,( semiology( and( frequency( of( epileptic( seizures( in( young(
people(with(22q11.2DS.(































6( Du( Montcel,( S.( T.,( Mendizabai,( H.,( Aymé,( S.,( Lévy,( A.( &( Philip,( N.( Prevalence( of( 22q11(
microdeletion.(Journal#of#Medical#Genetics(33,(719((1996).(









11( Swillen,(A.# et# al.( Intelligence(and(psychosocial( adjustment( in( velocardiofacial( syndrome:( a(
study( of( 37( children( and( adolescents(with( VCFS.( Journal# of#Medical# Genetics(34,( 453S458(
(1997).(
12( Edelmann,(L.,(Pandita,(R.(K.(&(Morrow,(B.(E.(LowScopy(repeats(mediate(the(common(3SMb(


















20( Driscoll,( D.# et# al.( Prevalence( of( 22q11( microdeletions( in( DiGeorge( and( velocardiofacial(
syndromes:( implications( for(genetic(counselling(and(prenatal(diagnosis.( Journal#of#Medical#
Genetics(30,(813S817((1993).(












syndrome:( results( from( the( International( Consortium( on( Brain( and( Behavior( in( 22q11.( 2(
Deletion(Syndrome.(American#Journal#of#Psychiatry((2014).(



























37( Antshel,( K.( M.# et# al.( Cognitive( and( psychiatric( predictors( to( psychosis( in( velocardiofacial(
syndrome:(a(3Syear(followSup(study.(Journal#of#the#American#Academy#of#Child#&#Adolescent#
Psychiatry(49,(333S344((2010).(






40( Vorstman,( J.( A.# et# al.( Cognitive( decline( preceding( the( onset( of( psychosis( in( patients(with(
22q11.(2(deletion(syndrome.(JAMA#psychiatry(72,(377S385((2015).(
41( Hooper,(S.(R.#et#al.(A(longitudinal(examination(of(the(psychoeducational,(neurocognitive,(and(
psychiatric( functioning( in( children( with( 22q11.( 2( deletion( syndrome.( Research# in#
developmental#disabilities(34,(1758S1769((2013).(
42( Schaer,(M.#et#al.(Deviant(trajectories(of(cortical(maturation(in(22q11.(2(deletion(syndrome(














49( Monks,( S.# et# al.( Further( evidence( for( high( rates( of( schizophrenia( in( 22q11.( 2( deletion(
syndrome.(Schizophrenia#research(153,(231S236((2014).(
50( Baker,( K.(D.(&(Skuse,(D.(H.(Adolescents( and(young(adults(with(22q11(deletion( syndrome:(
psychopathology(in(an(atSrisk(group.(The#British#Journal#of#Psychiatry(186,(115S120((2005).(
51( Van(Os,( J.,( Linscott,( R.( J.,(MyinSGermeys,( I.,( Delespaul,( P.( &( Krabbendam,( L.( A( systematic(
review(and(metaSanalysis(of(the(psychosis(continuum:(evidence(for(a(psychosis(proneness–
persistence–impairment(model( of( psychotic( disorder.( Psychological# medicine( 39,( 179S195(
(2009).(








55( Gothelf,(D.# et# al.(Clinical( characteristics(of( schizophrenia( associated(with( veloScardioSfacial(
syndrome.(Schizophrenia#research(35,(105S112((1999).(









of# the# American# Academy# of# Child# &# Adolescent# Psychiatry( 49,( 980S989,(
doi:https://doi.org/10.1016/j.jaac.2010.05.017((2010).(
60( Niklasson,(L.,(Rasmussen,(P.,(Óskarsdóttir,(S.(&(Gillberg,(C.(Autism,(ADHD,(mental(retardation(











64( Langley,( K.# et# al.( Adolescent( clinical( outcomes( for( young( people( with( attentionSdeficit(
hyperactivity(disorder.(The#British#Journal#of#Psychiatry(196,(235S240((2010).(





and( hyperactivity( in( velocardiofacial( syndrome.( Journal# of# child# and# adolescent#
psychopharmacology(21,(589S595((2011).(
68( Baxter,( A.,( Scott,( K.,( Vos,( T.( &( Whiteford,( H.( Global( prevalence( of( anxiety( disorders:( a(
systematic(review(and(metaSregression.(Psychological#medicine(43,(897S910((2013).(













74( Fine,( S.( E.# et# al.( Autism( spectrum( disorders( and( symptoms( in( children( with( molecularly(
confirmed(22q11.(2(deletion(syndrome.(Journal#of#autism#and#developmental#disorders(35,(
461S470((2005).(
75( Antshel,( K.(M.# et# al.( Autistic( spectrum( disorders( in( veloScardio( facial( syndrome( (22q11.( 2(
deletion).(Journal#of#autism#and#developmental#disorders(37,(1776S1786((2007).(
76( Vorstman,(J.(A.#et#al.(The(22q11.(2(deletion(in(children:(high(rate(of(autistic(disorders(and(early(




















84( Kessler,( R.( C.# et# al.( Prevalence,( persistence,( and( sociodemographic( correlates( of( DSMSIV(
disorders(in(the(National(Comorbidity(Survey(Replication(Adolescent(Supplement.(Archives#of#
general#psychiatry(69,(372S380((2012).(






87( Crockett,( D.( J.,( Goudy,( S.( L.,( Chinnadurai,( S.( &( Wootten,( C.( T.( Obstructive( sleep( apnea(
syndrome( in( children( with( 22q11.2( deletion( syndrome( after( operative( intervention( for(
velopharyngeal(insufficiency.(Front#Pediatr(2,(84,(doi:10.3389/fped.2014.00084((2014).(





90( Cunningham,(A.(C.#et#al.(Developmental(coordination(disorder,(psychopathology(and( IQ( in(
22q11.(2(deletion(syndrome.(The#British#Journal#of#Psychiatry(212,(27S33((2018).(
91( Van(Aken,(K.,(Caeyenberghs,(K.,(SmitsSEngelsman,(B.(&(Swillen,(A.(The(motor(profile(of(primary(














97( Kim,( E.SH.# et# al.( Epilepsy( and( Other( Neuropsychiatric( Manifestations( in( Children( and(
Adolescents(with(22q11.(2(Deletion(Syndrome.(Journal#of#Clinical#Neurology(12,(85S92((2016).(





100( Debbané,( M.,( Schaer,( M.,( Farhoumand,( R.,( Glaser,( B.( &( Eliez,( S.( Hippocampal( volume(
reduction(in(22q11.(2(deletion(syndrome.(Neuropsychologia(44,(2360S2365((2006).(




temporal( regions( related( to( schizophrenia?( American# Journal# of# Psychiatry( 158,( 447S453(
(2001).(
103( Kates,( W.( R.# et# al.( Temporal( lobe( anatomy( and( psychiatric( symptoms( in( velocardiofacial(
syndrome( (22q11.( 2( deletion( syndrome).( Journal# of# the# American# Academy# of# Child# &#
Adolescent#Psychiatry(45,(587S595((2006).(
( 28(
104( LeDoux,( J.( E.( Brain( mechanisms( of( emotion( and( emotional( learning.( Current# opinion# in#
neurobiology(2,(191S197((1992).(





WithoutSchizophrenia:( Preliminary( Results( of( a( Structural( Magnetic( Resonance( Imaging(
Study.(Archives#of#general#psychiatry(61,(1085S1096((2004).(







112( Engel( Jr,( J.( International(League(Against(Epilepsy( (ILAE).(A(proposed(diagnostic(scheme(for(
people(with(epileptic(seizures(and(with(epilepsy:(report(of(the(ILAE(Task(Force(on(Classification(
and(Terminology.(Epilepsia(42,(796S803((2001).(

















121( Graves,( R.( C.,( Oehler,( K.( &( Tingle,( L.( E.( Febrile( seizures:( risks,( evaluation,( and( prognosis.(
American#family#physician(85((2012).(












128( Meyer,( A.SC.,( Dua,( T.,( Ma,( J.,( Saxena,( S.( &( Birbeck,( G.( Global( disparities( in( the( epilepsy(
treatment(gap:(a(systematic(review.(Bulletin#of#the#World#Health#Organization(88,(260S266(
(2010).(
129( Bowley,( C.(&( Kerr,(M.( Epilepsy( and( intellectual( disability.( Journal# of# Intellectual# Disability#
Research(44,(529S543((2000).(
130( Blake,( R.,( Wroe,( S.,( Breen,( E.( &( McCarthy,( R.( A.( Accelerated( forgetting( in( patients( with(
epilepsy:(evidence(for(an(impairment(in(memory(consolidation.(Brain(123,(472S483((2000).(




133( Smith,( S.( EEG( in( the( diagnosis,( classification,( and(management( of( patients( with( epilepsy.(
Journal#of#Neurology,#Neurosurgery#&#Psychiatry(76,(ii2Sii7((2005).(











138( COMMISION,( O.( C.( TERMINOLOGY( OF( THE( INTERNATIONAL( LEAGUE( AGAINST( EPILEPSY.(









142( Clarke,( D.( F.# et# al.( The( prevalence( of( autistic( spectrum( disorder( in( children( surveyed( in( a(
tertiary(care(epilepsy(clinic.(Epilepsia(46,(1970S1977((2005).(
( 30(




















































syndrome–a( clinically( significant( association?( Journal#of# Intellectual#Disability#Research(48,(
695S698((2004).(





170( Lemke,( J.( R.# et# al.( Juvenile( myoclonic( epilepsy( with( photosensitivity( in( a( female( with(
































Children( who( have( taken( part( in( the( first( wave( of( assessment( are( therefore( reScontacted( and(
consented( into( further( waves( of( assessment.( These( longitudinal( assessments( employ( the( same(

































Informed( wrien( consent( was( obtained( from( the( primary( caregivers( of( parÄcipants,( and( from(



















more(willing( to( take(part,( particularly(with( respect( to( the(24Shour(EEG(assessment.( This(does(not(
appear(to(be(the(case(for(the(total(sample(of(deletion(carriers(who(took(part(in(the(second(assessment(
stage;(they(did(not(differ(in(their(fullSscale(IQ((FSIQ)(score,(rate(of(‘any(psychiatric(diagnosis’(or(the(
highest( level( of( parental( education( from( deletion( carriers( who( did( not( take( part( in( the( second(
assessment(stage.( (They(were(however(significantly(older((14.62(years(versus(12.39(years).(Control(
siblings(who(took(part(in(the(second(assessment(stage(also(showed(no(differences(on(these(measures(
from( those( that( did( not( take( part,(with( the( exception( of( their( FSIQ( score( (114.05( versus( 105.97,(
respectively).(Please(see(Section(5.4.1(for(a(full(description(of(these(results,(and(Section(5.5.1(for(a(


















‘Yes’(‘No’,( ‘Possibly’(or( ‘Don’t(know’.(A(positive(response(to(a(given( item(was(classified(as(‘Yes’(or(
Families take part in the 
ECHO study and complete the 
following measures:
Epilepsy Screen Questionnaire 
(completed by the primary caregiver)
 Deletion carriers  
Total n = 108 
n screening positive =  69
n screening negative = 39
Control siblings 
Total n= 60
n screening positive = 8
n screening negative  = 52
Cognitive assessment 
with the child  
Deletion carriers = 99
 Control siblings = 55
Psychiatric assessment with the 
primary caregiver and child
 Deletion carriers = 108 
Control siblings = 53
Screen for autism spectrum disorder, 
completed by the primary caregiver
Deletion carriers = 90
Control siblings = 48
Screen for developmental coordination 
disorder, completed by the primary 
caregiver
Deletion carriers = 95
Control siblings = 54
Positive screen on the 
Epilepsy Screen 
Questionnaire:
Unusual Spell Interview with 
primary caregiver 
Deletion carriers = 37*
 Control siblings = 4
Unusual Spell Interview with 
child
Deletion carriers = 16
 Control siblings = 1
Medical records relevant to the 
child's unusual spells  
Deletion carriers = 11
 Control siblings = 0
Video-recording of child's 
unusual spells 
Deletion carriers = 0 
Control siblings = 0
* 40 deletion carriers screening positive took 
part in the second assessment stage, but 
only 37 of these completed the primary 
caregiver interview. This is because the 
primary caregivers of three of these 40 
deletion carriers were unavailable for 
interview, but the child still took part in the 
EEG assessment
If during the Unusual Spell 
Interview, the child is reported as 
having repeated, stereotyped 
events, occuring within the last 
year:
Unusual Spell Diary for two months 
Deletion carriers = 19
 Control siblings = 3
Positive or negative screen on 
the Epilepsy Screen 
Questionnaire
24-hour ambulatory EEG with the child
Deletion carriers 
Total n =  44
n screening positive on ESQ = 28
n screening negative on ESQ = 16
Control siblings 
Total n = 23
n screening positive on ESQ = 4
n screening negative on ESQ = 19
Primary caregiver asked about a family 
history of epileptic seizures and epilepsy 
Deletion carriers = 37
  
Families who have 
completed the Epilepsy 
Screen Questionnaire 
are invited to take part in 
the second stage of the 
epilepsy assessment
Deletion carriers 
Total n = 56
n screening positive on ESQ = 40
n screening negative on ESQ = 16
Control siblings 
Total n= 23 
n screening positive on ESQ = 4
n screening negative on ESQ = 19
Stage 1 
Total N = 168 
Deletion carriers = 108 
Control siblings = 60
Stage 2 
Total N = 79 
Deletion carriers = 56 
Control siblings = 23
( 36(


































asked( the( primary( caregiver( to( complete( the( ESQ,( given( the( cognitive( deficits( associated( with(
22q11.2DS8S11(and(the(relatively(young(age(of(our(sample(of(deletion(carriers((13.6(years).(I(also(asked(
the(primary(caregiver(to(complete(all(nine(items(of(the(ESQ,(regardless(of(whether(or(not(their(child(
























If( the(primary(caregiver(gave(a(positive(response(to(at( least(one( item(of( the(ESQ,(I(asked(them(to(
complete( the( Unusual( Spell( Interview( about( the( child.( A( short,( supplementary( section( was( also(
completed(with(the(child,(if(they(were(6(years(or(older(at(the(time(when(they(were(having(their(unusual(
spells( (and(were( therefore( likely( to( remember( these( events).( The( interview( can( be( found( in( the(
Appendices.(The(Unusual(Spell(Interview(was(originally(developed(by((Ottman(et.(al(12,13(and(a(modified(
version(has(been(used(within(several(studies(conducted(as(part(of(the(Epilepsy(Phenome/Genome(


















I( referred( to( the( events( being( discussed( as( ‘unusual( spells’,( to( reflect( the( broad( nature( of( my(
assessment(of(epileptic(seizures(and(epilepsy.(The(original(interview(is(divided(into(sections(on(“grand(
mal”(seizures((a(traditional(name(for(generalised(tonicSclonic(seizures,(GTCS)(and(“small(seizures”((e.g.(
focal(motor(seizures).(Given(that( I(was(using(the( interview(for(broader(purposes(and( interviewing(
some(participants(who(didn’t(report(a(history(epilepsy(or(seizures,(I(combined(these(two(sections(into(
an( “unusual( spell”( section.( I( also( added( in( new( sections( for( febrile( seizures,( clinical(
investigation/medication( and( hypocalcaemia( diagnosis( and( treatment( (given( the( elevated( rate( of(
hypocalcaemiaSinduced(seizures(in(22q11.2DS,(1S14.5%2,4,17).(Finally,(I(created(a(new,(supplementary(
( 39(















Unusual(Spells’).( In( ‘Section(A:(Description(of(Unusual(Spells’,( ( the( interviewer( firstly( read(out( the(
primary( caregiver’s( responses( on( the( ESQ(and( asked( the( primary( caregiver( to( identify( how(many(









auras.( Finally,( the( interviewer( took( the( primary( caregiver( through( a( checklist( of( epileptic( seizure(
symptoms((‘Seizure/Unusual(Spell(Symptoms’),(e.g.(uncontrollable( jerking,(shaking,(head(turn,(eye(
rolling,( biting( of( the( cheek( or( the( side( of( the( tongue,( repetitive( lip( smacking( etc.( If( the( primary(
































































a( 24Shour( ambulatory( electroencephalography( (EEG)( assessment,( with( simultaneous(
electrocardiography((ECG)(and(with(overnight(videoSrecording.(The(recording(took(place(in(the(child’s(
home.(I(will(refer(to(this(from(now(on(as(the(‘caseScontrol(EEG(study’((Chapter(5).(The(equipment(to(














specific( for( epilepsy;( they( are( particularly( likely( to( occur( in( individuals( with( neurodevelopmental(
disorders(such(as(ASD(and(ADHD,(the(rates(of(which(are(elevated(in(22q11.2DS6,19,20.(Therefore,(even(
if( I(were(to(observe(a(preponderance(of(epileptiform(discharges( in(deletion(carriers(with(epileptic(











system,( electrodes( are( more( closely( spaced( at( 10%( intervals.( This( standardised,( proportional(




electrodes.( Sites( are( also( denoted( with( odd( or( even( numbers,( or( a( lowercase( ‘z’,( depending( on(
whether(they(are(situated(on(the(left(or(right(hemisphere,(or(midline,(respectively((e.g.(‘F4’,(‘C6’,(‘Oz’).(((
Diagrams(of(the(10S20(and(10S10(systems(are(provided(in(Figure(2S2.(In(EEG(recordings,(electrodes(can(
be( individually( glued( to( the( head.( In( clinical( EEG( recordings,( the( most( common( method( is( to(
individually( glue( 21( electrodes( to( the( scalp( (referred( to( from( now( on( as( the( ‘traditional( clinical(















common( to( both( electrodes( in( a( given( pair,( leaving( the( signal( of( interest.( Traditionally,( EEG(was(
displayed(via(an(analogue(method,(in(which(the(output(signal(caused(a(galvanometer((a(coil(of(wire(
inside(a(magnetic(field)(to(move(up(and(down.(This(galvanometer(was(attached(to(a(pen(and(thus(drew(
a( signal( onto(paper(moving(beneath( it.(However,(modern(EEG( systems(display( the( trace(digitally,(
allowing( for( flexible( manipulation( of( the( signal.( AnalogueStoSDigital( conversion( transforms( the(
waveform(into(numerical(values,(at(a(sampling(rate(of(256S512Hz.(The(EEG(trace(can(be(viewed(in(







The(EEG( signal( is( then(passed( through(numerous( filters,( so( that( activity( in( frequencies(of( interest(
(normally(1S30Hz(in(clinical(EEG)(can(be(viewed(clearly.(EEG(systems(currently(apply(three(different(
filters:),( a( highSpass( filter( that( attenuates( waveforms( with( a( lower( frequency( than( the( set( value(
(normally(0.3S1Hz),(a(low(pass(filter(that(attenuates(waveforms(with(a(higher(frequency(than(the(set(
value((normally(set(at(70Hz(and(a(notch(filter(to(remove(electrical(line(noise((set(at(50Hz(in(Europe(

















site( is( more( negative( than( the( common( reference( electrode( in( a( referential( montage,( or( the(
neighbouring( electrode( in( a( bipolar( montage).( Epileptiform( discharges( include( spikes,( lasting( for(
between(20(to(70(milliseconds,(sharp(waves((lasting(between(70(to(200(msec)(and(spike/sharpSandS
slowSwave(complexes.(In(a(referential(montage,(an(epileptiform(discharge(is(localised(by(looking(at(

















































missed( however,( as( the( 64Schannel( HCGSN( compensates( through( the( greater( head( coverage( it(
provides((as(compared(to(the(traditional(clinical(method,(using(only(21(channels).(













The( traditional( clinical( method( (i.e.( 21( silverSchloride( electrodes,( individually( glued( to( the( head(
according(to(the(10S20(electrode(placement(system)(was(used(during(pilot(EEG(study.(In( the(caseS









































































































and( left( the( family( home.( The( researchers( then( returned( to( the( family( home( in( the( morning.(




the( researchers( conducted( another( bioScalibration( session.( After( this,( the( researchers( started( the(
daytime(recording(and(left(the(family(home.(At(the(end(of(the(daytime(recording((defined(as(when(
roughly(24(hours(had(passed(since(the(start(of(the(study(the(night(before),(the(participants(returned(
and( removed( the( EEG( and( ECG( electrodes( and( ended( the( study.( The( children( and( their( primary(
caregiver(were(told(at(the(beginning(of(the(study(however(that(they(could(stop(taking(part(at(any(time(
they(chose(and(this(was(also(stated(in(the(consent(form(the(parent(signed.(
It( is( important( to(note( that( in( routine( clinical( EEG( recordings,( patients(with(a( clinically( suspicious(
paroxysmal( event( are( asked( to( hyperventilate( and( are( presented( with( photic( flashes( at( varying(
frequencies.(These(are(activation(procedures(which(increase(the(sensitivity(of(EEG(for(epileptiform(
discharges(and(which(may(also(induce(an(epileptic(seizure28.(Given(that(I(was(not(clinically(trained(and(






58cmS60cm.(Before(applying( the(net,( the( child’s(head( circumference(was(measured( to(determine(
which(net(size(should(be(used.(The(researchers(then(found(and(marked(the(vertex(on(the(scalp.(The(











study( (Chapter( 3).( For( one( child( in( the( caseScontrol( EEG( study( (Chapter( 5),( 9( electrodes( were(
individually(glued(to(the(head(for(the(overnight(portion(of(the(24Shour(recording,(see(Section(5.3.3.5(
for( further(details.( (Researchers(manually( identified(and(marked(each(electrode(site(on(the(scalp,(





































I( initially( screened( the( EEG( data( from( the( caseScontrol( EEG( study( (Chapter( 5)( for( background(






abnormality( and/or( an( epileptiform( discharge( and( in( which( case( they( provided( a( more( precise(
classification(of(the(abnormality((e.g.(focal/generalised(slowing,(focal/generalised(spike).(To(ensure(
that(I(was(able(to(accurately(identify(normal(EEG(variants,(background(abnormalities(and(epileptiform(
discharges,( at( the(beginning(of( the( review(process( the(epileptologist( and( I( together( reviewed( the(
entire(EEG(trace(for(five(deletion(carriers(and(five(sibling(controls.(It(must(be(acknowledged(however((




the( results( from( the( first( stage( of( the( systematic( assessment( of( epileptic( seizures( and( epilepsy(
assessment((i.e.(their(responses(on(the(ESQ)(and(all(of(the(available(data(from(the(second(stage(of(
assessment( (including( the( results( from( the( EEG( review).( The( epileptologist( stated( whether( each(
unusual(spell(could(be(diagnosed(as(an(epileptic(seizure(and(whether(the(child(could(be(diagnosed(
with(epilepsy.(Diagnostic( categories(were( ‘Yes’,( ‘Possible’,( ‘No’( and( ‘Uncertain’.( The(epileptologist(
then(made(further(classifications(of(seizure(semiology(and(aetiology;(this(was(to(be(as(specific(as(the(
available( information( would( allow( (for( example( for( seizure( semiology:( focal( seizure( –( further(
categorised(as( focal(motor( seizure(and( for( seizure(aetiology,( acute( symptomatic( seizure(–( further(
classified(as(hypocalcaemiaSinduced( seizure).(Diagnosis( and( classification(of( epileptic( seizures( and(
( 57(














This( subtest(measured(abstract( verbal( reasoning(and( verbal( concept( formation.( It( consisted(of( 26(
items,(the(first(four(of(which(were(pictures.(For(the(picture(items,(children(were(shown(three(pictures(
of(common(objects(on(the(top(row(of(the(page(and(were(then(asked(to(choose(which(picture(best(
















All( interviews( were( audiotaped.( Data( obtained( from( these( interviews( were( used( to( diagnose(





separation( anxiety,( panic( disorder( with( and( without( agoraphobia,( agoraphobia( and( obsessive(
compulsive(disorder).((
2.5.2! Screening(for(autism(spectrum(disorder(
Autism( spectrum( disorder( (ASD)( was( screened( for( in( the( child( using( the( Social( Communication(



















Sample( sizes( for( the( epilepsy,( cogniÄve,( psychiatric,( sleep,( motor( and( physical( health( problem(





with(a( rare( chromosomal(disorder.( Therefore,(both(my( supervisors( and( I( agreed( that( it(would(be(
appropriate(to(present(all(results(before(correction,(so(that(salient(findings(would(not(be(obscured(by(
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The(process(of( diagnosing(epilepsy( and( classifying( seizures( is( complex( and( is( conducted(by(highly(
experienced(epileptologists.(When(presented(with(a(patient(who(has(had(a(“blackout”,(the(clinician(
must(bear( in(mind(that( there(are(numerous(conditions(which(may(mimic( the( features(of(epileptic(






structured( Unusual( Spell( Interviews.( It( was( therefore( necessary( for( me( to( acquire( a( thorough(
understanding( of( the( features( that( distinguish( epileptic( seizures( from( nonSepileptic( events( and(







the( caseScontrol( EEG( study( (i.e.( the(24Shour( ambulatory(EEG(assessment(with( young(people(with(
22q11.2DS(and(their(control(siblings).(For(the(majority(of(children(in(this(study,(the(epileptologist(only(









collection.( This(would( allow(me( to( collect( data( as( efficiently( as( possible( from( young( people(with(
22q11.2DS,( a( cohort( whose( tolerance( for( prolonged( EEG( monitoring( is( likely( to( be( lower( than(
populations( without( the( deletion,( due( to( the( high( rates( of( cognitive( impairment( and( psychiatric(
disorder( seen( in( this( syndrome3S7.( I( aimed( to( use( the( 64Schannel( Hydrocel( Geodesic( Sensor( Net(
(HCGSN,(see(Section(2.3.7.4,(‘The#64-channel#Hydrocel#Geodesic#Sensor#Net’#for(further(details)(as(the(





are( however( greater( (n=8)( than(with( the( traditional( clinical(method( (n=2)( in( this( pilot( study.( The(









with( time( needed( to( allow( the( glue( (collodion)( to( set.( By( contrast,( when( using( the( HCGSN( the(


















Key( features( of( the( course( included( an( understanding( of( the( core( characteristics( that( distinguish(
epileptic(seizures(from(other(‘mimicking’(conditions((e.g.(syncope,(psychogenic(seizures),(as(well(how(






reviewed( routine( clinical( (i.e.( 30Sminutes)( and( 24Shour( ambulatory( EEG( recordings( from( children,(
adolescents( and( adults,( looking( for( background( abnormalities( and( epileptiform( discharges.( EEG(
recordings(were( conducted( using( the( traditional( clinical(method.( The( EEG( traces(were( viewed( in(
standard(clinical(montages,(including(bipolar((longitudinal(and(tranverse)(and(reference((common(and(



















64Schannel(HCGSN(and(the(21Schannel( traditional(clinical(method.( I(conducted(a( ‘wired’( recording(
with(all(children(in(this(pilot(study((see(Section(2.3.7.5(for(more(details).( I(also(did(not(include(the(

















distinguish( between( epileptic( seizures( and( nonSepileptic( events,( how( epilepsy( is( diagnosed,( how((
epilepsy(and(seizures(are(classified(according(to(ILAE(criteria(and(how(seizures(can(manifest(differently(
in(individuals(with(intellectual(disability.(Shadowing(the(clinical(EEG(review(sessions,(coupled(with(the(












didn’t(want( to( continue,( this(was( generally(because(the( children(didn’t(want( to(participate( in( the(
daytime(recording(after(having(worn(the(equipment(overnight.(Nine( (81.8%)(participants( reported(
that( the( equipment(was( uncomfortable( to( sleep( in.( Interestingly,( of( those( participants(who( then(
continued( into( the( daytime( recording( (n=5),( only( one( (20%)( reported( that( the( equipment( was(
uncomfortable(to(wear(during(the(daytime.(











been( properly( mapped( to( their( corresponding( channels( in( the( Galileo( Suite( Software( by( the(
















Diagnosing( epilepsy,( classifying( seizures( and( reviewing( EEGs( for( background( abnormalities( and(
epileptiform( discharges( are( complex( processes.( Proficiency( takes( many( years( of( clinical( training.(
Whilst(all(of(the(data(from(my(systematic(assessment(of(seizures(and(epilepsy((Chapters(4(and(5)(in(
young(people(with(22q11.2DS(would(be( reviewed(by( consultants( specialising( in(epilepsy(and(EEG(
review,(I(was(responsible(for(conducting(all(of(the(Unusual(Spell( Interviews(and(providing(an(initial(
screen( of( the( recordings( from( the( caseScontrol( EEG( study.( The( training( in( distinguishing( epileptic(
seizures(from(nonSepileptic(events,(seizure(classification(and(semiology(and(clinical(EEG(review(was(









young( people( with( 22q11.2DS( in( the( caseScontrol( EEG( study,( a( population( whose( tolerance( for(











this.( Firstly,( the( caseScontrol( EEG( study(was( conducted( in( tandem(with(a(polysomnography( (PSG)(
assessment(of(young(people(with(22q11.2DS(((the(project(of(another(PhD(student,(not(included(in(this(













In(conclusion,( the(training(and(pilot( research(discussed( in( this(chapter(allowed(me(to( improve(the(
quality(of(data(collection(during(the(systematic(assessment(of(seizures(and(epilepsy(in(young(people(










syndrome:( results( from( the( International( Consortium( on( Brain( and( Behavior( in( 22q11.( 2(
Deletion(Syndrome.(American#Journal#of#Psychiatry((2014).(
4( Swillen,(A.# et# al.( Intelligence(and(psychosocial( adjustment( in( velocardiofacial( syndrome:( a(






7( Niarchou,( M.# et# al.( Psychopathology( and( cognition( in( children( with( 22q11.( 2( deletion(
syndrome.(The#British#Journal#of#Psychiatry(204,(46S54((2014).(



























22q11.2DS,( but( associations( with( specific( psychiatric( diagnoses( (e.g.( ADHD)( and( other( salient(
manifestations(of( the(deletion( (e.g.( sleep(disturbance(and(motor(coordination(problems)(have(not(
been( explored( to( date.( This( chapter( compares( the( rates( of( an( epilepsy( diagnosis,( seizures( and(
paroxysmal( events( (behaviours(which( could(be( clinical(manifestations(of( seizures)(between(young(
people(with(22q11.2DS(and(their(control(siblings(without( the(deletion.( I(used(a(validated(epilepsy(
screening(questionnaire( for( this(purpose,( completed(by( the(primary( caregiver.( I( also(explored( the(
relationship( between( responses( on( this( questionnaire( with( cognition,( psychiatric( disorder,( sleep(











confers( significant( risk( for( epileptic( seizures( and( epilepsy,( and( suggest( that( epilepsy( may( be(
underdiagnosed( in( some( young( people( with( 22q11.2DS.( Given( the( limitations( of( the( screening(
questionnaire(however,(a(second(stage(of(assessment(of(the(reported(events(is(warranted(to(establish(
if(they(are(true(epileptic(seizures.(Our(findings(also(provide(further(evidence(for(a(reduced(seizure(
threshold( in( 22q11.2DS( and( emphasise( the( significant( risk( of( febrile( seizures( conferred( by( this(
syndrome.( The( relationships(of( epilepsy,( seizures( and(paroxysmal( events(with( impaired( cognition,(
psychopathology( and( developmental( coordination( disorder( I( observed( may( suggest( common(
neurobiological( risk( pathways( in( 22q11.2DS( (e.g.( aberrant( synaptic( plasticity),( or(
additionally/alternatively,(deleterious(effects(of(epileptic(seizures(on(cognitive,(psychiatric(and(motor(
development.(However,(the(broad(nature(of(the(paroxysmal(event(items(in(the(ESQ(may(mean(that(












general( population)4,5.( The( high( rate( of( acute( symptomatic( seizures( in( 22q11.2DS,( relative( to( the(
general(population,(has(led(some(authors(to(suggest(that(the(22q11.2(deletion(may(lower(the(seizure(





prevalence( of( these( phenomena( in( 22q11.2DS.( This( is( because( the( extent( and( quality( of( clinical(
documentation(may( differ( between( clinicians( and(medical( centres,( as( well( as( the( diagnostic( and(
classifications(systems(used.(Factors(such(as(these(may(explain(why(estimates(of(the(prevalence(of(






disorders( that( families( of( an( individual( with( 22q11.2DS( have( to( manage.( If( subtle,( stereotyped(
paroxysms(seem(to(lead(to(no(obvious(impairment(in(an(individual(with(22q11.2DS,(their(caregivers(
may(prioritise(time(with(clinicians(to(speak(about(other(conditions(that(are(having(a(more(obvious(or(
serious( impact( (e.g.( congenital( heart( disease,( autism( spectrum( disorder,( ASD).( NonSconvulsive(
seizures(usually(have(to(occur(several(times(before(the(affected(individual(and(their(family(become(
concerned(and(seek(clinical(help9.(((
Only( one( study( has( conducted( a( systematic,( firstShand( investigation( into( epileptic( seizures( and(
epilepsy(in(22q11.2DS,(involving(examination(by(an(epileptologist,(magnetic(resonance(imaging((MRI)(
and( electroencephalography( (EEG)( assessment.( They( found( that( 36.8%( of( deletion( carriers( had(
epilepsy,(although(this(was(only(in(a(small(sample((n=19)(of(adults7.((
Two(studies(have(attempted(to(characterise(the(association(of(epileptic(seizures(and(epilepsy(with(










been( underpowered( and( their( sample( of( young( people(with( 22q11.2DS(may( not( have( accurately(
represented( the( population.( In( addition,( the( associations( of( epilepsy( with( specific( psychiatric(
diagnoses((e.g.(ADHD)(were(not(reported6.(
Whilst(findings(to(date(of(the(associations(of(epileptic(seizures(and(epilepsy(with(neurodevelopmental(




In( summary( then,( studies( exploring( epileptic( seizures( and( epilepsy( in( 22q11.2DS( have( shown( an(
elevated( prevalence,( but( the( reliance( on( historical(medical( record( review(may( explain( the( wideS


















































slightly( increase(the(sensitivity(of( the(ESQ(for(epilepsy( (from(91%(to(94%)14.( I( therefore(separated(
these( items( from( the(more( specificallySworded( items( related( to( an( epilepsy( diagnosis( and( febrile(
seizures((Items(1(and(9).(
(The( amendments( I(made( to( the( original( version( of( the( ESQ( are( described( in( Chapter( 2( (Section(
2.3.1.2).((
4.3.3! IQ(and(ID(















Scores( range( from( 15( to( 75,( with( the( discrimination( thresholds( for( indicative( developmental(
coordination(disorder((DCD)(based(on(age.(Sleep(disturbance(was(defined(as(a(score(of(two(on(at(least(
one( item(of( the(sleep(section(of( the(CAPA,(which(asks(about( insomnia,(hypersomnia,(nightmares,(
tiredness,(fatigability,(night(terrors(and(somnambulism.((
4.3.6! Physical(health(problems(
Primary(caregivers(provided( informaÄon(on(preterm(birth( (before(37(weeks( for(a(single(baby(and(



















sibling)( and( the( ‘any( posiÄve’( (yes/no)( summary( variable,( whilst( factoring( in( age( and( gender.(








status( predicted( recurrent( infecÄons( (yes/no).( Given( the( strong( associaÄon( of( 22q11.2DS( with(





In( this(secÄon,( I(aimed(to(carry(out( crossSsecÄonal(analyses(of( the(relaÄonships(between(the(ESQ(
variables(and(cogniÄon,(psychopathology,(sleep(disturbance(and(motor(problems.(However,(the(ESQ(




























European+ 92((85.2)( ( ((
Mixed+ 11((10.2)( ( ((
NonZEuropean+ 2((1.9)( ( ((
Unknown+ (3((2.8)( (( ((
Highest+Parental+Qualificationa+
++ My+Sample+ Equivalent+categories+from+Lawson+et+al.+(2013)b+
Low+(OZLevels/GCSEs)+ 25((23.1)( High+School+or+below+ 45((15.9)(
Middle+(AZLevels/highers/vocational+
training)+ 35((32.4)( Some+College+ 78((27.6)(
High+(university+degree+and/or+other+




≤+£19,999+ 24((22.2)( ≤+$25,000+ 13((4.6)(
£20,000+Z+£39,999+ (26((24.1)( $25,001Z$50,000+ 57((20.1)(
£40,000+Z+£59,999+ 23((21.3)( $50,001Z$75,000+ 68((24)(
≥£60,000+ 25((23.1)( >+$75,000+ 145((51.2)(
Unknown+ 10((9.3)( S(
Age+
++ Mean++ SD+ Range+
22q11.2DS+ 13.6( 3.3( 6.2S20.5(
Control+siblings+ 12.7( 2.9( 6.3S18.9(
Gender+
++ Male+(%)+ Female+(%)+ ((
22q11.2DS+ 62((57.4)( 46((42.6)( ((

































1.+ Did+ your+ son/daughter+ ever+ have+ a+ seizure+ or+
convulsion+caused+by+a+high+fever?a+ 26((24.3)( 0((0)( 17( _( <0.001(
2.+ Other+ than+ the+ seizures+ associated+ with+ high+
fevers,+ has+ your+ son/daughter+ ever+ had+ a+ seizure,+
convulsion,+fit,+or+spell+Z+under+any+circumstances?b+
26((24.1)( 0((0)( 16.8( _( <0.001(
3.+ Other+ than+ the+ seizures+ associated+ with+ high+
fevers,+has+your+son/daughter+ever+had+uncontrolled+
movements+ of+ part+ or+ all+ of+ their+ body+ such+ as+
twitching,+jerking,+shaking+or+going+limp?c++
21((19.8)( 2((3.3)( 8.72( 7.1( 0.003(
4.+ Other+ than+ the+ seizures+ associated+ with+ high+




19((17.8)( 1(1.7)( 9.44( 12.6( 0.002(
5.+Does+your+ son/daughter+daydream+or+ stare+ into+
space+more+than+other+children?d+ 43(40.2)( 5(8.3)( 19( 7.31( <0.001(
6.+Have+you+ever+noticed+them+to+have+any+unusual+








after+ a+ nap,+ have+ you+ ever+ noticed+ that+ your+
son/daughter+ has+ had+ uncontrollable+ jerking+ or+


























































(( 22q11.2+DS+ +Control+siblings+ ((( (( ((
Measure+ n+ Mean+ s.d.+ n+ Mean+ s.d.+ t+ 95%+CI+ pZvalue+
FSIQ+ 99( 72.05( 12.29( 55( 108.58( 15.3( 15.19( 31.76,(41.31( <0.001(
PIQ+ 99( 75.24( 12.83( 55( 109.29( 16.62( 13.17( 28.91,(39.18( <0.001(
VIQ+ 100( 73.13( 12.67( 55( 106.45( 14.77( 14.12( 28.64,(38.01( <0.001(
Neurodevelopmental+
problem+ Total+ Yes+(%)+ No+(%)+ Total+ Yes+(%)+ No+(%)++ χ
2+ OR+ pZvalue+
ID+ 99( 42((42.4)( 57((57.6)( 55( 0(0)( 55((100)( 32.08( S( <0.001(
Any+psychiatric+
disorder++ 108( 53((49.1)( 55((50.9)( 53( 2((3.8)( 51((96.2)( 32.44( 24.19( <0.001(
ADHD+ 106( 30((28.3)( 76((71.7)( 47( 1((2.1)( 46(97.9)(( 13.81( 17.96( <0.001(
Any+anxiety+disorder+ 108( 31((28.7)( 77((71.3)( 49( 2((4.1)( 47((95.9)( 12.3( 9.36( <0.001(
Any+sleep+problem+ 107( 63((58.9)( 44((41.1)( 50( 10((20)( 40((80)( 20.7( 5.66( <0.001(
Indicative+ASD+ 90( 37((41.1)( 53((58.9)( 48( 0((0)( 48((100)( 26.96( S( <0.001(











b" z+ OR+ pZvalue+
No+(s.d.)+ Yes+(s.d.)+
FSIQ+ 99( 73.94((13.31)( 70.35((11.15)( S0.02( S1.39( 0.98( 0.163(
PIQ+ 99( 78.49((14.05)( 72.31((10.94)( S0.04( S2.36( 0.96( 0.018(







b" z+ OR+ pZvalue+
No+(%)+ ++Yes+(%)+
ID++ 42(/(99( 17((36.2)( 25((48.1)( 0.44( 1.02( 1.55( 0.921(
Any+psychiatric+disorder++ 53(/(108( 33((56.9)( 20((40)( 0.76( 1.87( 2.13( 0.062(
ADHD++ 30(/(106( 10((20)( 20((35.7)( 1.19( 2.32( 3.28( 0.021(
Any+anxiety+disorder+ 31(/(108( 11((22.0)( 20((34.5)( 0.6( 1.36( 1.83( 0.175(
Any+sleep+problem+ 63(/(107( 31((62)( 32((56.1)( S0.24( S0.59( 0.79( 0.558(
Indicative+ASD++ 37(/(90( 11((25.6)( 26((55.3)( 1.35( 2.86( 3.86( 0.004(




























4.5.1! Prevalence(of(epilepsy,(seizures(and(paroxysmal(events( in(22q11.2DS(and( in(control(
siblings(
The(rate(of((reported)(epilepsy(diagnoses(that(I(observed(in(young(people(with(22q11.2DS((11.1%)(was(
in( line( with( previous( estimates,( as( obtained( from( medical( records2S4,6,8,15( As( mentioned( in( the(
introduction,(one(possible(limitation(of(these(studies(is(that(the(reliance(on(medical(record(review(
may(mean( that( deletion( carriers(who( have( not( been( seen( clinically( for( epileptic( seizures(may( be(
missed.(This(may(be(particularly(likely(for(patients(with(nonSmotor(absence(seizures(and(focal(nonS
motor( seizures( with( impaired( awareness.( My( preliminary( questionnaire( findings( provide( some(
support(to(this(idea,(given(that(when(deletion(carriers(with(an(epilepsy(diagnosis(or(a(febrile(seizure(









with( 22q11.2DS30.( ( Indeed,( individuals( with( cognitive( impairments( are( particularly( likely( to( be(
misdiagnosed( with( epilepsy31.( In( the( validation( study( conducted( by( Ottman( et( al.14( (described( in(

















The(rate(of( reported( febrile(seizures( in(young(people(with(22q11.2DS(was(21.1%(when(cases(with(
epilepsy(were(excluded((increasing(slightly(to(24.3%(when(cases(with(epilepsy(were(included).(This(is(
considerably( higher( than( in( previous( studies( in( this( patient( group( (2S6%2S4)( and( in( the( general(
population((2S5%32).(This(supports(the(hypothesis(of(a(reduced(seizure(threshold(in(22q11.2DS,(for(
















A( reduced( seizure( threshold( in( 22q11.2DS( could( be( brought( about( by( the( structural( brain(
abnormaliÄes( associated( with( 22q11.2DS( (e.g.( polymicrogyria,( focal( corÄcal( dysplasia,( reduced(
number( and( length( of( dendrites16,33)( and( the( impact( these(may( have( on( the( balance( of( neuronal(
excitatorySinhibitory(signalling.(As(outlined(in(secÄon(1.7.3.1,(the(elevated(rate(of(hypocalcaemia(in(
22q11.2DS1(may( addiÄonally( contribute( to( this( reduced( seizure( threshold( by( enhancing( neuronal(
excitability34.(Future(studies(should(explore(the(relaÄonships(between(febrile(seizures,(infecÄons(and(








22q11.2DS( impairments( in( a( variety( of( neurocognitive( domains( (including(working(memory)( have(
been(observed11,( as(well( as(white(matter( abnormalities39.( In( addition,( a(high( rate(of(hippocampal(






indicaÄve( DCD( and( a( lower( PIQ( in( our( sample( of( young( people( with( 22q11.2DS( have( several(
implicaÄons:(
1.! One( the( one( hand,( these( relaÄonships( are( in( line(with( the( associaÄons( of( epilepsy( with(
impaired( cogniÄon,( psychopathology( and( motor( problems,( observed( in( the( general(
populaÄon17,20,21,41(and(therefore(may(suggest(shared(neurobiological(risk(pathways(for(these(





pruning( in( the( cerebellum43.( SynapÄc( plasÄcity( in( the( prefrontal( cortex( is( important( in(
adolescent( development( of( execuÄve( funcÄon,( a( behavioural( impairment( in( ADHD44.(
Impaired( hippocampal( synapÄc( plasÄcity( shows( links( with( memory( deficits45,46.( Aberrant(
synapÄc(plasÄcity(is(also(implicated(in(the(emergence(of(the(sensory,(cogniÄve,(motor(and(







The( aberrant( synaptic( plasticity( in( these(mouse(models( is( mediated( by( dysregulation( of(
( 91(






life( seizures( may( therefore( have( deleterious( effects( on( a( vulnerable( neural( network( in(
22q11.2DS( for( example,( within( hippocampal( and( prefrontal( regions7,46,50,( leading( to( the(








mean( that( in( some( cases( positive( responses( represent( behaviours( associated( with( ID,(
psychopathology(and(other(neurodevelopmental(problems(seen(in(22q11.2DS1,30,(rather(than(
true( epileptic( seizures.( If( this( is( the( case,( then( it( is( no( surprise( I( observed( significant(
associations( between( ‘any( positive’( on( the( ESQ( and( neurodevelopmental( problems( in(
deletion( carriers.( These( associations,( and( conclusions( about( shared( neurobiological( risk(
pathways(in(22q11.2DS,(therefore(need(to(be(interpreted(with(caution.(A(second(stage(of(
assessment(is(warranted(to(delineate(these(ESQSreported(events((distinguish(trueSpositives(
from( falseSpositives)( and( better( assess( the( validity( of( the( relationships( with(
neurodevelopmental(problems,(observed(in(this(chapter.((




polysomnography( assessment( may( provide( a( more( accurate( estimation( of( sleep( problems( in(
22q11.2DS(and(allow(us(to(better(assess(their(relationship(with(epileptic(seizures(and(epilepsy.(
( 92(
In( conclusion,( the( findings( from( this( chapter( clearly( reinforce( that( not( only( are( children( with(





need( to( distinguished( from( falseSpositives( in( order( to( assess( the( validity( of( these( relationships.( I(
demonstrated(further(evidence(for(a(reduced(threshold(for(acute(symptomatic(seizures(in(22q11.2DS(
through( the( high( rate( of( febrile( seizures( (24.3%)( reported( in( my( cohort( of( deletion( carriers.(
Highlighting( the( prevalence( of( epileptic( seizures( and( epilepsy( and( their( relationship( with(
neurodevelopment( in( 22q11.2DS( could( allow( more( focused( monitoring( of( and( intervention( for(
epileptic(seizures(by(clinicians.(This(could(improve(the(outcomes(of(young(people(with(this(syndrome.(
Ultimately(then,(it(is(essential(that(the(events(reported(in(the(ESQ(undergo(a(second,(detailed(stage((
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as( revealed( by( taskSbased( fMRI.( Epilepsy# Res( 108,( 1286S1298,(
doi:10.1016/j.eplepsyres.2014.06.015((2014).(





















consultant( epileptologist,( who( identified( epileptiform( discharges( and( diagnosed( and( classified(
epileptic(seizures(and(epilepsy(according(to( the(most( recent( International(League(Against(Epilepsy(
(ILAE)( guidelines.( I( also( sought( to( better( delineate( salient( characteristics( of( epileptic( seizures( in(
22q11.2DS(that(have(not(been(addressed(to(date(in(previous(studies(of(deletion(carriers,(and(which(










positive( deletion( carriers( who( were( subsequently( diagnosed( with( nonSepileptic( events( had( a(
significantly(lower(PIQ(and(higher(rates(of(ADHD,(indicative(ASD(and(DCD.(I(found(that(5/6(deletion(
carriers( with( an( ESQSreported( epilepsy( diagnosis( (and( who( were( available( for( interview)( were(
confirmed(as(having(epilepsy(by(the(epileptologist.(Interestingly,(two(deletion(carriers(who(had(not(
( 97(
been( reported( with( an( epilepsy( diagnosis( in( the( ESQ( were( diagnosed( with( epilepsy( by( the(
epileptologist(in(this(second(assessment(stage.(In(one(these(individuals(however,(there(was(evidence(
from( the(medical( records( that( they( had( been( previously( given( a( clinical( diagnosis( of( epilepsy.( By(
contrast,(only(11.8%((2/17)(of(individuals(who(were(reported(with(an(afebrile(seizure(or(a(paroxysmal(
event((in(the(absence(of(epilepsy(or(a(febrile(seizure)(were(diagnosed(with(‘possible’(epileptic(seizures(
by( the( epileptologist.( These( were( repeated( ‘possible’( nonSmotor( absence( seizures( in( both( cases,(




an( epilepsy( diagnosis( (and( who( were( available( for( interview)( had( these( confirmed( by( the(
epileptologist,( supporting( the( findings( from( Chapter( 4( and( reinforcing( that( the( 22q11.2( deletion(
confers(significant(risk(for(febrile(seizures(during(childhood,(as(well(as(a(reduced(seizure(threshold.(




clinicians.( The(majority(of(unprovoked( seizures( in( this( study(were(of( ‘primary( genetic’( origin( (e.g.(
thought( to( be( a( direct( consequence( of( the( deletion,( rather( than( a( secondary( consequence( of( a(
structural( brain( abnormality)( and( were( generalised,( providing( further( evidence( for( a( strong(
association(between(22q11.2DS(and(genetic(generalised(epilepsy((GGE).(Unprovoked(seizures(did(not(
meet( criteria( for( status(epilepticus(but(30%(of(participants( reported( that,( at( their(most( frequent,(
seizures(were(occurring(daily,(which(in(the(general(population(confers(significant(risk(for(a(more(severe(
epilepsy(phenotype((e.g.(drugSresistant(epilepsy).(9.1%(of(deletion(carriers(showed(brief(spikeSandS
slowSwave( discharges( of( atypical(morphology( on(EEG,( occurring( during( sleep( and/or( shortly( after(
awakening.( These( were( not( significantly( elevated( relative( to( the( control( siblings( however( (0%,(
p=0.290),( or( more( frequent( in( deletion( carriers( with( epileptic( seizures( (15.4%)( relative( to( those(








with( 22q11.2DS,( although( there( was( a( trend( toward( a( greater( proportion( of( deletion( carriers(
diagnosed(with(epilepsy(having(ADHD(and(indicative(ASD.(I(also(did(not(find(significant(relationships(
between(nonSepileptic(events(and(these(poorer(neurodevelopmental(outcomes,(but(observed(a(trend(
toward( a( greater( proportion( of( deletion( carrier( diagnosed(with( nonSepileptic( events( having( DCD.(






risk( for( acute( symptomatic( seizures( and( repeated( unprovoked( seizures( (i.e.( epilepsy),( although(
reported( rates( are( wideSranging.( For( example,( studies( have( reported( that( between( 1S14.5%( of(
deletion(carriers(have(hypocalcaemiaSinduced(seizures,(whilst(between(4.4S36.8%(have(epilepsy1S7.(
Differences( in( the(extent(of( clinical( documentation(and(diagnostic( criteria(between( clinicians( and(
medical(centres(may(help(to(explain(the(wideSranging(prevalence(estimates(for(epileptic(seizures(and(
epilepsy(in(22q11.2DS.(In(addition,(these(reviews(may(have(failed(to(account(for(nonSmotor(absence(




The( vast( majority( of( studies( exploring( epileptiform( and( background( abnormalities( through(
electroencephalography((EEG)(recordings(in(22q11.2DS(have(also(similarly(relied(on(historical(medical(
record(review2S4,6,9( (however,(see(the(study(by(Andrade(et.(al1( for(a( firstShand(assessment).(These(
studies( have( identified( epileptiform( discharges(which( can( be( focal,(multifocal( or( generalised( and(






















of( ( epilepsy( in( the( general( population( (lifetime( prevalence( of( 0.5S3%,( assumed( to( be( 2%( when(
calculating(the(PPV(in(the(validation(study10).(The(prevalence(of(epilepsy(in(22q11.2DS(is(thought(to(
be( higher( however( (4.4S36.8%1S5,7).( (My( first( aim( of( this( study(was( to( conduct( a( second( stage( of(
assessment(in(a(subSsample(of(deletion(carriers(and(control(siblings(screening(positive(on(the(ESQ,(to(
determine(whether(their(reported(events(represented(epileptic(seizures.(This(second(stage(comprised(




and( epileptic( seizures,( and( identified( epileptiform( discharges.( The( caseScontrol( EEG( study( also(
included(deletion(carriers(and(control(siblings(who(had(screened(negative(on(the(ESQ.(This(was(done(
to(better(delineate(whether(epileptiform(discharges(are(associated(with(epilepsy(risk(in(22q11.2DS,(as(
opposed( to( being( a(more( general( feature( of( the( neurodevelopmental( disorders( conferred( by( the(
deletion((e.g.(ADHD(and(ASD,(disorders(in((which(the(rate(of(epileptiform(discharges(is(elevated13,14),(
although( see( Section( 2.3.7.2( for( a( discussion( of( the( potential( pitfalls( of( interpreting( epileptiform(




paroxysmal( event( questions( however,( not( all( those( reported( as( having( an( afebrile( seizure( or(
paroxysmal(event(would(be(diagnosed(with(epileptic(seizures(by(the(epileptologist.(3.(The(rates(of(
( 100(
background( abnormalities( and( epileptiform( discharges( would( be( significantly( higher( in( deletion(






seizures.( The( most( common( acute( symptomatic( seizure( experienced( by( young( people( with( this(
syndrome(are(hypocalcaemiaSinduced((10S15%(of((young(people(with(22q11.2DS,(43S67.7%(of(young(
deletion( carriers(with( epileptic( seizures( )3,5.( Amongst( deletion( carriers( unprovoked( seizures,( focal(
seizures(of(varying(aetiologies( (e.g.( focal(cortical(dysplasia,(polymicrogyria)(are( the(most( common(
(44%)9.(People(with(22q11.2DS(also(show(an(elevated(rate(of(unprovoked(seizures(with(a(‘primary(
genetic’(origin( (i.e.( seizures(are( thought( to(be(a(direct(consequence(of( the(deletion,( rather( than(a(
secondary( consequence( of( structural( brain( abnormalities).( More( specifically,( 22q11.2DS( shows( a(
strong(association(with(genetic(generalised(epilepsy.(It(affects(between(1S8.3%(of(deletion(carriers(
(27%(of(deletion( carriers(with(unprovoked( seizures)( and( the(deletion(occurs( in( significantly(more(
people(with(GGE((0.2%,(3/1,366)(than(without((0/5,234,(p=8.85ES03(2S4,6,9,15.(Further(characteristics(of(
unprovoked(seizures(that(I(aimed(to(better(delineate(were(seizure(onset,(length(and(frequency.(Whilst(
previous( studies( of( groups( of( individuals( with( 22q11.2DS( have( described( the( age( of( onset( of(
unprovoked( seizures( in( young( people( with( 22q11.2DS( (8( monthsS( 5.99( years)2,3,( they( have( not(
described( the( average( length( or( frequency( of( seizures.( Increased( seizure( length( and( frequency(
associate(with(poorer(developmental(outcomes(in(the(general(population.(For(example,(particularly(
prolonged( seizures( (those( over( 30(minutes)(may( lead( to( neuronal( injury,( death( and( alteration( of(
neuronal(networks16.((Similarly,(seizure(frequency(significantly(predicts(poorer(healthSrelated(quality(
of( life,( including(general(health,(social( functioning(and(mental(health17.( In(addition,(having(weekly(
epileptic(seizures(significantly(increases(the(risk(of(developing(drugSresistant(epilepsy18.(In(summary,(
I(hypothesised(that(1.(Whilst(the(most(common(unprovoked(seizure(semiology(in(deletions(carriers(

















association( of( ESQSreported( febrile( seizures( with( impaired( cognition,( psychopathology,( sleep(
disturbance( and( motor( coordination( problems( (see( Section( 4.4.2).( I( therefore( hypothesized( that(
febrile(seizures(in(22q11.2DS(would(not(present(with(‘complex’(features(and(would(not(meet(criteria(
for(FSE.((




















epileptic( seizures( and( epilepsy( (with( ‘negative’( cases( including( those( who( were( either( screened(
( 102(
negative(on(the(ESQ(or(who(screened(positive(but(were(diagnosed(with(nonSepileptic(events(during(









observed( in( the(general(population26S29,( I(hypothesized(that( individuals(with(epileptic(seizures(and(
epilepsy(would(have(lower(performance(IQ(and(higher(rates(of(ADHD,(indicative(ASD(and(indicative(




















The( Unusual( Spell( Interview,( originally( developed( by( Ottman( et( al.30,31,( was( conducted( with( the(
primary( caregiver( if( they(had(given(a(positive( response( to( at( least(one( item(of( the(ESQ( .(A(short,(
supplementary(section(was(also(conducted(with(the(child,(where(appropriate((see(Section(2.3.2.1).(I(
used(the(Unusual(Spell(Interview(to(acquire(a(more(detailed(description(of(the(events(described(in(the(




























I( conducted( a( 24Shour( ambulatory( EEG( assessment(with( young( people(with( 22q11.2DS( and( their(
control(siblings,(in(the(family(home((referred(to(in(previous(chapters(as(the(‘caseScontrol(EEG(study’.(
As(outlined(in(Section(2.3.7.2,(I( invited(any(child(for(whom(I(had(ESQ(data(to( take(part(in( the(EEG(
assessment,(regardless(of(whether(they(had(screened(positive(or(negative.(This(was(to(assess(whether(







section( 2.3.7.5,( ‘Procedure# when# using# the# 64-channel# HCGSN’( for( a( description( of( the( setSup(
procedure(when(using(this(method.(One(deletion(carrier(wore(a(continuous(positive(airway(pressure(
(CPAP)(mask( for(sleep(apnoea(and(was(therefore(unable( to(wear( the(HCGSN(during(the(overnight(
(sleep)(recording.(For(this(child,(we(used(the(‘traditional(clinical(method’(for(the(overnight(recording.(
(see(Section(2.3.7.5,(‘Procedure#when#using#the#traditional#clinical#method’#for(a(description(of(the(setS
















I( compared(deletion(carriers(who(did( take(part( in( the(second(stage(of(assessment(with(those(that(
didn’t,(across(a(number(of(dimensions,(in(order(to(test(for(bias(in(the(subSsample(described(in(this(
chapter.(I(used(!2(tests((with(Fisher’s(Exact(Test(when(appropriate)(to(compare(gender(and(the(rate(







Interview.(For(each(of( these(variables,(I( then(calculated(the(percentage(of( those( followed(up(with(
Unusual(Spell(Interview(who(had(their(ESQSreport(confirmed(by(the(epileptologist.(For(the(epilepsy(















symptomatic( seizures( in(my( sample(had( febrile( seizures.( I( therefore( calculated( the( percentage(of(
deletion(carriers(who(had(febrile(seizures(and(no(other(acute(symptomatic(seizure(and(the(percentage(








the( longest(seizure( for(deletion(carriers(with(seizures(of(differing( lengths.( I(calculated(the(median(
number( of( febrile( seizures( across( all( deletion( carriers.( For( unprovoked( seizures,( I( calculated( the(
percentage(of(deletion(carriers(who(endorsed(each(of(the(four(frequency(categories((in(response(to(




I( explored( the( association( between( deletion( status( (22q11.2DS/( control( sibling)( and( epileptiform(
discharges((present/absent)(using(a(Fisher’s(Exact(Test.(A(Fisher’s(Exact(Test(was(also(used(to(explore(
the(association(between(epileptic( seizures( (yes/no)( and(epileptiform(discharges( (yes/no)( in( young(
people(with(22q11.2DS.(
5.3.6.5! Family(history(of(epileptic(seizures(and(epilepsy(in(young(people(with(22q11.2DS(
I( explored( the( association( between( a( family( history( of( epileptic( seizures( and/or( epilepsy(
(present/absent)( and(whether( a(deletion( carrier(was(diagnosed(with( an(epileptic( seizure( (yes/no)(
using(a(Fisher’s(Exact(Test.(














events( had( a( significantly( lower( performance( IQ( and( higher( rates( of( ADHD,( indicative( ASD( and(
indicative(DCD,(this(could(suggest(these(individuals(were(driving(the(significant(association(between(
‘any( positive’( and( these( neurodevelopmental( outcomes( that( I( observed( in( Chapter( 4.( This(would(
subsequently(suggest(these(associations(may(not(be(valid.(
As( menÄoned( in( SecÄon( 2.1,( the( ECHO( study( has( obtained( cogniÄve,( psychiatric( and( other(











































aOf the 19 deletion carriers who met criteria for the Unusual Spell Diary, only two were 
diagnosed with epileptic seizures by the epileptologist 
bNone of the control siblings who met criteria for the Unusual Spell Diary were diagnosed 
with epileptic seizures by the epileptologist 
c28 deletion carriers who took part in the EEG assessment screened positive on the 
Epilepsy Screening Questionnaire and 16 screened negative 
dFour control siblings who took part in the EEG assessment screened positive on the 



























Age:+mean+(s.d.)+ 14.62((3.24)( 12.39((3.02)( 13((3.5)( 13.14((2.99)(
Gender:+n+(%)+ (( (( (( ((
++ Male+ 30((53.6)( 32((61.5)( 11((47.8)( 19((51.4)(
++ Female++ 26((46.4)( 20((38.5)( 12((52.2)( 18((48.6)(
FSIQ:+mean+(s.d.)+ 72.41((12.94)( 70.91((11.17)( 114.05((13.67)( 105.97((14.30)(














In( young( people( with( 22q11.2DS,( 83.3%( (5/6)( deletion( carriers( reported( as( having( an( epilepsy(
diagnosis,(who(were(subsequently(interviewed,(had(their(diagnosis(confirmed(by(the(epileptologist.(
The( remaining( individual( did( not( meet( criteria( for( an( epilepsy( diagnosis( as( the( epileptologist(
determined( they( had( only( one( neonatal( unprovoked( generalised( tonicSclonic( seizure( (GTCS).( Two((
individuals(who(were(reported(with(a(history(of(afebrile(seizures((Item(2(from(the(ESQ,(see(Table(2S1(






‘Epilepsy’(was( listed(as( a(diagnosis( in( a( child(development( clinic( letter( (see( Table(5S4).( The( other(






were(never(completed(as( the(staring(spells(stopped.( ( Interestingly,( this(child(showed(epileptiform(











































ESQ:+epilepsy+diagnosis++ 12/108((11.1)( 6/12((50)( 5/6((83.3)(
ESQ:+febrile+seizurea + 20/95((21.1)b( 14/20((70)( 13/14((92.9)(
ESQ:+afebrile+seizure+or+

















































































































































































































































10! Febrile!seizure!(1)! Febrile!seizures! USI,!EEG!recording!
4!months!(febrile!
seizures)! No! No! P!
11! Febrile!seizure!(1)! Febrile!seizure! USI,!EEG!recording!
18!months!(febrile!























































seizures)! No! No! P!
15! Febrile!seizure!(1)! Febrile!seizure! USI! 12!months!(febrile!seizure)!
Did!not!take!part!in!
EEG!study! No! P!



































































































cases).! Another! individual! had! an! acute! symptomatic! seizure! (focal! motor)! shortly! after! cardiac!
surgery!(4.5%,!1/22).!An!additional!individual!had!an!acute!symptomatic!seizure!as!a!neonate!(focal!
motor,!possibly! to!bilateral! tonic*clonic)!after!hypoxic*ischaemic!encephalopathy! (4.5%,!1/22).!The!
rate! of! unprovoked! seizures! was! 45.5%! (10/22).! In! 60%! of! these! individuals,! no! clear! structural!
aetiology! was! reported! and! so! these! were! categorised! as! having! a! ‘primary! genetic’! origin! by!
epileptologist.!In!the!remaining!40%,!unprovoked!seizures!were!linked!to!structural!aetiologies,!which!
included! right! hemisphere! polymicrogyria,! perinatal! subdural! haematoma,! neonatal! hypoxic*





















febrile! seizure,! with! one! individual! having! experienced! seven.! The! vast! majority! of! unprovoked!
seizures!were!generalised.!The!median!age!of!onset!was!within!the!first!three!years!of!life.!On!average,!
unprovoked! seizures! lasted! for! 135! seconds! (just! over! two! minutes).! At! their! most! frequent,!














































Febrile'' 17! 17!(100)! 0!(0)! 14!(0)168)! 150!(10)900)! 2!(1)7)!
=' =' =' =' ='









44!young!people!with!22q11.2DS!and!23! control! siblings! took!part! in! the!24>hour!EEG! study.! The!
overall!mean!recording!length!was!13:32:49!(s.d.!=!05:08:33),!ranging!from!02:51:09>22:01:58).!Table!





waves.!By!contrast,! in!a!more! ‘typical’!generalised!spike>and>slow!wave!discharge,! the!spike>wave!




showing! abnormalities! shortly! after! awakening! were! away! from! the! camera).! Figure! 5>1! shows!
examples! of! these! abnormalities! during! sleep! (top! panel)! and! awakening! (bottom! panel).! These!
epileptiform!discharges!were!equally! likely! to!occur! in!deletion!carriers!who!were!diagnosed!with!





Deletion(status( n(( Mean(length(of(recording((s.d.)(( Range(of(recording(lengths( Epileptiform(discharge((%)(
22q11.2DS! 44! 13:23:25!(05:11:59)! 03:26:10>22:01:58! 4/44!(9.1)!









































































carriers!diagnosed!with!epilepsy!during! the! second!assessment! stage!having!ADHD! (57.1%!versus!
28.3%,! p=0.193)! and! indicative! ASD! (85.7%! versus! 57.1%,! p=0.224).! Interestingly,! the! rates! of!
indicative!DCD!were!equal!between!those!who!were!or!were!not!diagnosed!with!any!epileptic!seizure!
during!the!second!assessment!stage!(75!versus!75.9%,!p=1)!but!was!slightly!lower!in!those!diagnosed!










!! !! Any(epileptic(seizure(( (( (( ((
Measure( n( No(( Yes( W( OR( pCvalue(






No((%)( Yes((%)( χ2( OR( pCvalue(
ADHD! 17/53! 9!(29)! 8!(36.4%)! 0.32! 1.39! 0.573!
Indicative!ASD! 30/49! 17!(60.8)! 13!(61.9)! 0.01! 1.05! 0.933!
Indicative!DCD! 37/49! 22!(75.9)! 15!(75)! >! 0.96! 1!
!! !! !! !! !! !! !!
!! !! Epilepsy(diagnosis( !! !! !!
Measure( n( No(( Yes( W( OR( pCvalue(






No((%)( Yes((%)( χ2( OR( pCvalue(
ADHD! 17/53! 13!(28.3)! 4!(57.1)!! >! 3.3! 0.193!
Indicative!ASD! 30/49! 24!(57.1)! 6!(85.7)! >! 4.39! 0.224!
Indicative!DCD! 37/49! 32!(76.2)! 5!(71.4)!! >! 0.79! 1!
!! !! !! !! !! !! !!
!! !! NonCepileptic(event( !! !! !!
Measure( n( No(( Yes( W( OR( pCvalue(






No((%)( Yes((%)( χ2( OR( pCvalue(
ADHD! 15/37! 8!(36.4)! 7!(46.7)! 0.39! 1.5! 0.531!
Indicative!ASD! 22/35! 13!(61.9)! 9!(64.3)! 0.02! 1.1! 0.886!







afebrile!seizure!or!paroxysmal!events,! reported! in! the!ESQ,! in!a!sub>group!of!my!sample!of!young!
people! with! 22q11.2DS! and! controls! siblings.! In! addition,! I! aimed! to! better! delineate! salient!
characteristics! of! epileptic! seizures! in! young! people! with! 22q11.2DS,! such! as! their! length! and!
frequency.! I! also!wanted! to! assess! the! extent! to!which! a! family! history! of! epileptic! seizures! and!
epilepsy!may!confer!risk!for!epileptic!seizures!in!deletion!carriers.!I!therefore!completed!interviews!
with!the!primary!caregiver!and!child,!obtained!relevant!medical>records!about!these!events!and!asked!
the! primary! caregiver! to! record! how! often! these! events! occurred! in! a! two>month! diary.! I! also!
conducted!a! 24>hour! ambulatory!EEG!assessment!with! the! child! and!asked! the!primary! caregiver!

















































deletion! carriers! with! febrile! seizures! and! took! notes! according! to! a! set! of! questions! that! were!
systematically!applied!across!all!cases.!By!directly!interviewing!families,!I!may!also!have!detected!cases!
of! febrile! seizures!which!were!not! seen! clinically! and! therefore!would!not!have!been! included! in!
medical!record!reviews.!!
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Agreement! between! the! ESQ! and! epileptologist! diagnoses! was! poorer! for! the! group! of! deletion!
carriers!reported!with!an!afebrile!seizure!or!paroxysmal!event!(in!the!absence!of!an!epilepsy!diagnosis!
or!febrile!seizure)!on!the!ESQ.!Of!those!deletion!carriers!available!for!interview!(n=17),!two!(11.8%)!
were! diagnosed!with! ‘possible’! epileptic! seizures! by! the! epileptologist,!with! the! rest! having! non>
epileptic!events.!The! findings! from!my!sub>sample!therefore!suggest! that! the!majority!of!deletion!
carriers!reported!with!an!!afebrile!seizure!or!paroxysmal!event!(in!the!absence!of!an!epilepsy!diagnosis!





from! ! the!validation!study!of! the!ESQ,!conducted!by!Ottman!et!al.10;! individuals!with!and!without!






























symptomatic! seizures! during! childhood,! predominantly! febrile! seizures! (77.3%),! but! also!
hypocalcaemia>induced! seizures! (9.1%)! and! those! associated! with! surgery! (4.5%)! and! hypoxic>
ischaemic!encephalopathy!(4.5%).!These!findings!indicate!that!the!22q11.2!deletion!leads!to!a!reduced!
seizure! threshold! for!many! triggers! including! fever,! hypocalcaemia,! ischaemia! and! the! impact! of!
prolonged!or!complex!surgical!procedures!on!the!central!nervous!system!(CNS).!During!adulthood,!the!
study!by!Wither!et!al.!indicated!that!the!main!trigger!appears!to!be!psychotropic!drug!use!(65.6%!of!




available! in! this!study! (n=37)!compared!to!previous!medical! record!reviews! (348! in!Kao!et!al.3).! In!
addition,!the!rate!of!hypocalcaemia!in!my!sample!of!deletion!carriers!(35%,!13/37!deletion!carriers!
with!this!data!available)!was!lower!than!that!typically!seen!in!22q11.2DS!(~50%)37,!which!may!explain!











and!were!all!generalised.!However,! it! is! important! to!note!that!one!of! the!criteria! for! the! ‘simple’!














of! young! people! with! 22q11.2DS,! febrile! seizures! had! a! median! age! of! onset! of! 14! months.!
Importantly,!there!is!evidence!to!suggest!that!recurrent!febrile!seizures!significantly!increase!the!risk!
of!afebrile!seizures40.!It!is!therefore!essential!that!future!studies!carefully!monitor!the!association!of!









The!majority! (60%)! of! unprovoked! seizures! in! this! sample! of! young! people!with! 22q11.2DS!were!
‘primary! genetic’! (i.e.! thought! to!be!a!direct! result! of! the!22q11.2!deletion).! In! addition,! the! vast!




in! 22q11.2DS,! (44%,! 39/88),! followed! by!GGE! (27%,! 24/88).! This! discrepancy!may! be! due! to! the!
relatively! small! number! of! patients! with! unprovoked! seizures! in! my! study! (10),! compared! to!
Mudigoudar’s!review!(88).!!
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In! this! study,! I!was! also! interested! in!better!delineating! the! length!and! frequency!of!unprovoked!
seizures!in!young!people!with!22q11.2DS,!given!the!association!of!these!seizure!characteristics!with!












having! focal!motor! seizures! (post>ictal! left>sided!numbness!upon!awakening),! possible!non>motor!
absences!and!GTCS!seizures!with!non>motor!absences,!respectively.!In!the!general!population,!having!
weekly! seizures! significantly! increases! the! risk! of! developing! drug>resistant! epilepsy18.! The! three!
deletion!carriers!with!daily!unprovoked!seizures!in!this!study!may!therefore!be!at!significant!risk!of!a!





however,!only! two! individuals!with!unprovoked!seizures!met!criteria! for! the!diary.! In!one!case!no!
seizures!(nocturnal!GTCS)!occurred!over!the!two>month!period!and!in!the!other!(possible!non>motor!
absence!seizures)!the!diary!was!not!returned.!To!avoid!these!issues,!future!studies!could!ask!families!




estimates!of! the!average!age!of!onset!of!unprovoked!seizures! in!medical! record!reviews!of!young!
people!with!22q11.2DS,!which!range!from!8!months!to!5.99!years2,3.!When!considered!alongside!the!
median!age!of!onset!of!febrile!seizures!observed!in!my!study!(14!months),!these!findings!suggest!that!
young!people!with!22q11.2DS!are!at! significant! risk! for!both!acute! symptomatic! and!unprovoked!
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seizures!during!the!early!years!of!life.!!Young!children!diagnosed!with!22q11.2DS!should!arguably!be!
closely!monitored! for! epileptic! seizures!by! clinicians! from!early! in! life.! In! addition,! young! children!
presenting!with! febrile!seizures!and/or!unprovoked!seizures,! in!combination!with!congenital!heart!




















contrast,! in! typical! generalised! spike>and>slow>wave! discharges,! the! spike>wave! pattern! repeats,!
usually!at!3Hz.!One!possible!explanation!for!the!unusual!morphology!is!that!some!of!these!waveforms!
I!observed!may!be!‘epileptiform!K>complexes’,!which!are!composed!of!an!initial!spike,!followed!by!a!!
K! complex.! K>complexes! are! normal! sleep! phenomena! which! are! thought! to! be! responsible! for!
suppressing!arousal!responses!to!non>threatening!stimuli34.!They!typically!occur!during!lighter!sleep!
stages! (Stage! 2),! but! can! be! seen! in! deep! slow! wave! sleep.! Interestingly,! examination! of! the!
background!activity!seen!when!these!atypical!spike>wave!discharges!occurred!suggested!the!deletion!
carriers!were!lighter!sleep!stages,!although!it!is!important!to!note!I!did!not!formally!score!sleep!stages.!














toward!a! greater!proportion!of!deletion! carriers!with!epileptic! seizures!having! these!epileptiform!
discharges! (15.4%,! 2/13),! than! those! without! epileptic! seizures! (6.5%,! 2/31).! The! non>significant!




not! taking! part! in! EEG! were! often! that! they! would! poorly! tolerate! this! measure! due! to! ongoing!
cognitive,!behavioural!and!psychiatric!difficulties.!Although!there!were!no!significant!differences!in!











potentially! containing! an! abnormality.! It! is! possible! therefore! that! I! may! have! missed! salient!
background!and!epileptiform!abnormalities!in!the!children.!However,!I!mitigated!this!risk!through!the!
















No! significant! association! was! observed! between! a! positive! family! history! and! the! presence! of!
epileptic!seizures!and/or!epilepsy!and/or!epileptiform!discharges!in!deletion!carriers.!This!contrasts!
with! findings! in! the! general! population,! in! which! a! family! history! is! known! to! associate! with! an!
increased!risk!of!epilepsy!and!abnormal!EEG!findings25.!In!this!sample!I!had!data!about!family!history!
in! a! sub>set!of!deletion! carriers! (37/108)! and! only! six!deletion! carriers! reported!a!positive! family!
history,! so!my! findings!may!be!affected!by!a! lack!of!power.! In! addition,!only!one!deletion! carrier!





5.5.6! Associations! of! epileptic! seizures,! epileptiform! discharges! and! epilepsy! with!
neurodevelopmental!problems!in!22q11.2DS!
In! this!chapter,! I!did!not!observe!any!associations!between!any!epileptic!seizures!and!PIQ,!ADHD,!





observed! in!Chapter!4.! Importantly!however,! I!did!observe!trends!toward!a!greater!proportion!of!
deletion!carriers!diagnosed!with!epilepsy!having!ADHD!and!indicative!ASD!than!those!not!diagnosed.!
This!may!suggest!that!the!significant!associations!of!‘any!positive’!on!the!ESQ!with!ADHD!and!indicative!
ASD,! observed! in! Chapter! 4,! are! the!most! likely! to! be! valid! (i.e.! reflect! an! association! with! true!
positives).!In!addition,!in!this!chapter!I!observed!that!a!greater!proportion!deletion!carriers!diagnosed!
with!non>epileptic!events!during!the!second!assessment!stage!had!indicative!DCD,!although!this!trend!





therefore! remains! unclear! whether! the! true>positives! or! false>positive! are! driving! the! significant!
association! of! ‘any! positive’!with! indicative! DCD.! Due! to! the! small! sample! sizes! (e.g.! 22! deletion!




seizures! and! epilepsy! are! required! to! better! explore! the! association! of! these! phenomena! with!
neurodevelopmental! trajectories! and! better! assess! the! validity! of! the! relationships! I! observed! in!
Chapter!4.!One!immediate!future!direction!would!be!to!ensure!all!individuals!screening!positive!on!

















severe! developmental! impairment.! Despite! this,! febrile! seizures! in! 22q11.2DS! should! be! closely!
monitored!as! they!are! recurrent! and!generally! start!within! the! first! 18!months!of! life,! potentially!
increasing! the! risk! of! subsequent! afebrile! seizures.! The! findings! from! this! study! also! support! an!
increased! risk! for! unprovoked! seizures! in! 22q11.2DS,! notably! generalised! seizures!with! a! genetic!
aetiology.!The!unprovoked!seizures!in!my!sample!did!not!meet!criteria!for!status!epilepticus,!but!in!
some!deletion!carriers!they!were!highly!frequent,!potentially!conferring!risk!for!a!more!severe!epilepsy!
phenotype! and! therefore!warranting! close! attention! from! clinicians.! I! did! not! observe! significant!
associations!of!epileptic!seizures!and!epilepsy!with!PIQ,!ADHD,!indicative!ASD!and!indicative!DCD!in!
young!people!with!22q11.2DS,!although!trends!toward!a!greater!proportion!of!deletion!carriers!with!
epilepsy!having!ADHD!and! indicative!ASD!were!observed.! In!addition,! I!observed!a!non>significant!
trend! toward!a! greater!proportion!of!deletion! carriers!with!non>epileptic! events!having! indicative!
DCD.!Future!research!should!attempt!to!incorporate!all!deletion!carriers!screening!positive!on!the!ESQ!
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poor! neurodevelopmental! outcomes.! Case! reports! and! larger! studies! have! sought! to! explore! the!
prevalence!of!epileptic!seizures!and!epilepsy!in!22q11.2!deletion!syndrome!(22q11.2DS),!but!these!


























•! Review! of! any! video>recording! of! the! events! reported! in! the! ESQ! (however,! none! were!
provided)!





epileptic! seizures! and!assess! to!what!extent!epileptiform!discharges!were!associated!with!




All! of! the! data! from! these! measures! was! then! reviewed! by! a! consultant! epileptologist! (with! a!

















•! Problems! with! motor! coordination.! The! Developmental! Coordination! Disorder!








young! people! with! 22q11.2DS.! Further! systematic! assessment! of! these! events! was!warranted! to!
determine!whether!they!represented!‘true’!epileptic!seizures.!I!also!observed!that!21.1%!of!deletion!
carriers!were!reported!as!having!febrile!seizures!(in!the!absence!of!an!epilepsy!diagnosis,!24.3%!when!
cases!with!epilepsy!were! included),!which!provided!support! to! the! idea!that! the!22q11.2!deletion!
leads! to!a! reduced!seizure!threshold.!Finally,! I! found!that!young!people!with!22q11.2DS!with! ‘any!
positive’! had! significantly! lower! PIQ! and! higher! rates! of! attention>deficit! hyperactivity! disorder!
(ADHD),! indicative! autism! spectrum! disorder! (ASD)! and! indicative! developmental! coordination!
disorder! (DCD).!This!may!suggest!common!neurobiological! risk!pathways! for! these!deficits,!one!of!
which!may!be!aberrant!synaptic!plasticity25>29.!Additionally!or!alternatively,!these!associations!may!be!
explained! through! deleterious! effects! of! epileptic! seizures! on! cognitive,! psychiatric! and! motor!
development!in!22q11.2DS25,30,31.!However,!it! is! important!to!highlight!that!these!associations!with!












in! this! thesis! that!epileptic!seizures!may!not!be!recognised!in!some!young!people!with!22q11.2DS!
during! routine! clinical! care! and! that! an! epilepsy! diagnosis!may! be! overlooked.! This! conclusion! is!
limited!by! the! ‘possible’! nature!of!of! some!of! these! diagnoses,! brought! about! ! by! the! limitations!
















aetiology,! providing! further! support! for! the! robust! association! between! 22q11.2DS! and! genetic!
generalised!epilepsy!(GGE)!observed!in!previous!studies1,2,4,5,38.!I!also!observed!that!of!those!deletion!
carriers!with!unprovoked!seizures,!!around!a!third!were!having!them!at!least!once!a!day!at!some!point!
in! their! lifetime,!which! in! the! general! population! significantly! increases! the! risk! of! drug>resistant!
epilepsy39.!Brief!spike>and>slow>wave!epileptiform!discharges!of!atypical!morphology!were!observed!
during! sleep! and/or! shortly! after! awakening! in! 9%! of! deletion! carriers,! but! this! rate! was! not!
significantly! elevated! relative! to! controls! and! no! significant! association! was! found! with! epileptic!
seizures,!so!it!is!currently!not!clear!to!what!extent!they!are!associated!with!epilepsy!risk!in!22q11.2DS.!
I!did!not!provide!evidence!that!a!family!history!of!epileptic!seizures!and/or!epilepsy!increases!the!risk!






more! likely! to!have! indicative!DCD.! !These!analyses!may!ultimately!have!been! limited!by!a! lack!of!













carriers! screening! positive! on! the! ESQ!were! having! non>epileptic! events.! Despite! this,! during! the!
second! stage! of! assessment! I! still! observed! rates! of! acute! symptomatic! seizures! and! isolated! or!
















the! 24>hour! EEG! assessment.! Medical! records! were! available! for! the! other! deletion! carrier! and!
suggested!that!they!had!already!received!a!clinical!diagnosis!of!epilepsy!prior!to!taking!part!in!this!
study! (despite! the! primary! caregiver! not! reporting! this! in! the! ESQ! or! during! the! Unusual! Spell!
Interview),! suggesting! that! primary>caregiver! report!with! the! ESQ!may! sometimes! lead! to! under>









likely! associated! with! the! methodological! limitations! of! the! ‘remote’! epileptologist! assessment!
employed!during!this!stage!(discussed!below!in!Section!6.4.1).!In!addition,!further!findings!from!the!









Wither! et! al.4! suggested! the! idea! of! a! reduced! seizure! threshold! in! adults!with! 22q112.DS,! after!
observing! that,! in! deletion! carriers! with! a! seizure! history,! 71%! had! acute! symptomatic! seizures,!
typically!associated!with!hypocalcaemia!and!psychotropic!drug>use.!More!specifically,!they!observed!
that!17.6%!of!individuals!exposed!to!psychotropic!drugs!had!acute!symptomatic!seizures.!By!contrast,!







second! stage! of! assessment! were! confirmed! as! having! febrile! seizures! (with! a! non>complex!
phenotype)!by!the!epileptologist,!suggesting!the!high!rate!from!the!first!stage!is!likely!to!be!accurate.!
Whilst! this!high! rate!of! febrile! seizures!points! toward!a! reduced! seizure! threshold,! an!alternative!
! 151!
explanation!for!this!finding!could!be!that!deletion!carriers!are!simply!experiencing!more!infection>
related! high! fevers! than! neurotypical! individuals,! brought! about! by! the! immunological! problems!
strongly! associated! with! this! syndrome42.! Indeed,! I! observed! that! recurrent! infections! were!
significantly!more!prevalent! in!deletion! carriers! (68.9%)! relative! to! controls! (10.9%)! in!my! sample!!
(p<0.001).! Similarly,! of! those! deletion! carriers! with! febrile! seizures,! a! greater! percentage! had!
recurrent! infections! (80.8%! versus! 19.2%),! however! this! difference!was! not! significant! (p=0.257).!
There!were!however!limitations!to!these!analyses,!namely!that!deletion!carriers!were!not!asked!about!
a! lifetime! history! of! recurrent! infections.! As! discussed! in! Section! 4.5.1,! the! lack! of! a! significant!





neuronal! excitability44,! thereby! disturbing! neuronal! excitation>inhibition! balance.! Whilst!
hypocalcaemia!is!one!of!the!most!important!risk!factors!for!febrile!seizures!in!the!general!population45,!
during!the!second!!stage!of!assessment!I!observed!that!only!35.3%!of!deletion!carriers!diagnosed!with!
febrile!seizures!had!hypocalcaemia.!Therefore,!whilst!hypocalcaemia!may!be! important! for! febrile!
seizure!risk!in!22q11.2DS,!other!factors!may!also!contribute!to!the!lower!seizure!threshold!and!the!
increased!risk!for!febrile!seizures!in!this!syndrome.!
6.2.3! Epileptic! seizures! and! epilepsy! may! associate! with! poorer! neurodevelopmental!
outcomes!in!young!people!with!22q11.2DS!
In!Chapter!4,!I!observed!that!deletion!carriers!who!screened!positive!on!the!ESQ!(‘any!positive’)!were!
significantly! more! likely! to! have! ADHD,! indicative! ASD! and! indicative! DCD,! as! well! as! a! lower!
performance!PIQ.!These!findings!have!several!implications:!!











have! meant! that! in! some! cases! the! ESQ! was! detecting! behaviours! associated! with! the!
cognitive! impairment! and! psychopathology! in! 22q11.2DS32,! rather! than! true! epileptic!
seizures.!These!hypothetical!false>positives!could!have!been!driving!the!association!of!‘any!
positive’!with!poorer!neurodevelopmental!outcomes.!During!the!second!stage!of!assessment!





reflect! a! genuine! association!with! true>positives).! Notably,! I! also! observed! that! a! greater!
proportion! of! deletion! carriers! diagnosed! with! non>epileptic! events! had! indicative! DCD,!
although!this!trend!was!non>significant.!It!is!also!important!to!note!that!the!rate!of!indicative!
DCD! in! individuals! who! were! diagnosed! with! epileptic! seizures! was! also! high,! so! it! is!
inconclusive! from! these! analyses! whether! false>positives! could! solely! account! for! the!
relationship!of!‘any!positive’!with!indicative!DCD.!Analyses!of!the!relationships!of!epileptic!
seizures,! epilepsy! and! non>epileptic! events! with! poorer! neurodevelopmental! outcomes!
(Chapter!5)!were!likely!limited!by!a!lack!of!power!(e.g.!only!7!deletion!carriers!were!diagnosed!
with! epilepsy! in! the! second! stage! of! assessment).! These! analyses! therefore! cannot! fully!
address! the! validity! of! the! relationships! of! the! ‘any! positive’! ESQ>variable! with! poorer!
neurodevelopmental! outcomes.! Future! research! should! focus! on! incorporating! all! of! the!
deletion!carriers!reported!with!‘any!positive’!into!the!second!stage!of!assessment,!so!that!the!
validity!of!these!relationships!can!be!accurately!assessed.!Until!then,!the!significant!overlap!








6.2.4! Plausible! genetic! and! neurobiological! mechanisms! underpinning! epilepsy! risk! in!
22q11.2DS!
What!are! the!genetic!and!neurobiological!mechanisms!which!could!confer!increased!risk!for!wide>
ranging! epileptiform! phenomena,! a! reduced! seizure! threshold! and! the! possible! association! with!
comorbid!cognitive!impairments,!ADHD,!ASD!and!motor!problems!in!young!people!with!22q11.2DS?!
As!discussed!in!the!Section!1.7.3.2,!the!deletion!appears!to!confer!risk!for!a!range!of!structural!brain!
abnormalities! that! are! associated! with! epileptic! seizures.! These! include! diffuse! cerebral! atrophy,!
polymicrogyria,!grey!and!white!matter!heterotopia!and!focal!cortical!dysplasia6.!In!Chapter!5!of!this!
thesis,! 40%! of! deletion! carriers! with! unprovoked! seizures! reported! structural! aetiologies! (in! the!
Unusual!Spell!Interview!and/or!medical!records)!including!right!hemisphere!polymicrogyria,!perinatal!
subdural!haematoma,!neonatal!hypoxic>ischaemic!encephalopathy!and!possible!post!pneumococcal!
meningitis.! In! addition! to! these! specific! abnormalities,! people!with! 22q11.2DS!may! have! broader!
neuronal! deficits,! such! as! aberrant! synaptic! plasticity! and! a! pervasive! imbalance! in! neuronal!
excitation>inhibition,!which!in!the!general!population!been!associated!with!epileptic!seizures,!ASD,!
impaired!cognition,!ADHD!behaviours!and!problems!with!motor!coordination25>29,50.!Mouse!models!of!
22q11.2DS! have! demonstrated! aberrant! synapqc! plasqcity.! For! example,! hemizygosity! for! the!
microRNA!biogenesis!gene!Dgcr8! leads! to!enhanced! short!and! long>term!synaptic!plasticity!within!
hippocampal!CA3>CA1!synapses,!coinciding!with!spatial!memory!deficits,!as!well!as!enhanced!short>
term! depression! in! the! prefrontal! cortex.! Mice! that! are! haploinsufficient! for! the! mitochondrial!
function!gene!Mrpl40!also!show!abnormal!short>term!potentiation!within!the!hippocampus!and!co>
occurring! working! memory! deficits.! The! aberrant! synaptic! plasticity! in! these! mouse! models! is!
mediated!by!dysregulation!of!presynaptic!calcium!levels!and!neurotransmitter!release!(e.g.!enhanced!














for! epileptic! seizures! in! young! people!with! 22q11.2DS.! Clinicians! should! arguably! closely!monitor!
deletion!carriers!for!seizures!during!these!years.!This!is!particularly!important!given!the!associations!I!





fever! reduction! for! febrile! seizures,! anti>epileptic! drugs! for! repeated! unprovoked! seizures)! may!
significantly!improve!long!term!outcomes!in!young!people!with!22q11.2DS.!
6.3.2! Genetic!testing!for!the!22q11.2!deletion!
My! findings! highlight! the! prevalence! of! epileptic! seizures! and! epilepsy! in! young! people! with!
22q11.2DS.!If!young!people!present!with!these!phenomena,!in!addition!to!other!typical!features!of!
22q11.2DS! (e.g.! congenital! heart! disease,! palatal! abnormalities,! cognitive! impairment! and!
psychopathology),!they!should!arguably!be!referred!for!genetic!testing!for!the!22q11.2!deletion.!!!
















general! design! of! my! study! is! that! it! relied! on! ‘remote’,! rather! than! ‘direct’! assessment! by! an!
epileptologist.! Throughout! this! thesis! I! have! described!my! systematic! assessment! of! seizures! and!






two! deletion! carriers! diagnosed! with! ‘possible’! absence! seizures.! I! attempted! to! mitigate! this!
limitation! by! using! validated! instruments! to! collect! data! about! epileptic! seizures! and! epilepsy!





report! in! the! ESQ! and/or! the! Unusual! Spell! Interview.! However,! it! must! be! noted! that! direct!
epileptologist! assessment! might! have! improved! the! quality! of! my! findings.! For! example,! in! the!
deletion! carriers!with! ‘possible’! absence! seizures! the! epileptologist!would! have! been! able! to! ask!
further! questions! that! could! have! provided! a! more! definitive! diagnosis.! To! further! mitigate! the!










enough! to! detect! important! relationships.! For! example,! a! lack! of! power!may! explain! the! lack! of!























should! also! strive! to! obtain! video! recordings! of! unusual! spells,! ideally! with! simultaneous! EEG!
recordings,!particularly!when!direct!epileptologist!assessment!is!not!possible.!This!would!provide!a!
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gold>standard! means! of! diagnosing! epileptic! seizures! and! epilepsy,! overcoming! some! of! the!
limitations! of! witness! report! associated! with! the! Unusual! Spell! Interview! used! in! this! thesis! (for!








with! epileptiform! discharges! (but! no! prior! history! of! epileptic! seizures! or! epilepsy)! could! help! to!





6.5.3! Assessment! of! epileptic! seizures,! epilepsy! and! epileptiform! discharges! in! larger!
22q11.2DS!cohorts!!
To!avoid! the! limitations!associated!with!a! lack!of!power!discussed! in!Section!6.4.2,! future!studies!
should! conduct! assessments! of! epileptic! seizures! and! epilepsy,! as! well! as! their! association! with!
neurodevelopmental!trajectories,!in!larger!cohorts!of!people!with!22q11.2DS.!This!could!for!example!




















only!seven!individuals.! Incorporating!epilepsy!assessments! into!the!22q! IBBC!framework!therefore!
seems!a!more!plausible!short>term!solution! for!assessing!epileptic!seizures!and!epilepsy!in!a! large!











carriers! during! routine! clinical! care,! and! an! epilepsy! diagnosis! may! be! overlooked.! In! addition,! I!
observed! a! far! higher! rate! of! febrile! seizures! than! previous! estimates! in! this! population,! which!
provides! further! support! for! a! reduced! seizure! threshold! in! this! syndrome.! Finally,! I! found! some!
preliminary!evidence!for!an!overlap!of!epileptiform!phenomena!with!!!higher!rates!of!ADHD,!ASD!and!
motor! problems,! as! well! as! a! lower! PIQ,! in! this! syndrome,! although! this! particular! finding! has!





assessment! and! review! of! video>recordings! of! unusual! spells! are! warranted! to! overcome! the!
limitations! of! this! thesis.! These! studies! have! the! potential! to! provide! greater! insight! into! the!
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How are you completing this interview? 
 
o! With participant present 






()= the interviewer needs to choose from one of the options inside the brackets 
 
SMALL CAPS=instructions to interviewer 
 
Caregiver ID:  
 
Relationship of caregiver to child:   
 




Child age:    
Child gender (M/F):  
 
 
















Part 1: Febrile seizures 
 








Please think back to a specific time (name of child) had one of these event s. It could be the first time (s/he) had 
one, the time (s/he) had one most recently, or the time you feel you can describe the best. I would like to get a 










IF CHILD HAS SCREENED POSITIVE ON QUESTION 1 OF EPILEPSY SCREEN, COMPLETE THE FOLLOWING 
SECTION. OTHERWISE, SKIP TO PART 2: ‘OTHER  SEIZURES’. 
From the questionnaire we sent you asking about seizures and epilepsy, you said that 
 
□ (Name of child) had a seizure or convulsion caused by a high fever 
 
□ (Name of child) possibly had a seizure or convulsion caused by a high fever 
 
 
INTERVIEWER READS THE FOLLOWING 
I’d now like to ask some more questions about the seizure or convulsion caused by a high fever that (name of child) 










What would you say is the very first thing that happened when (name of child) had this event ?  
PROBE TO SPECIFY DETAILS 
PROBE FOR WHETHER CHILD HAD ANY INFECTIONS IN THE AROUND THE TIME OF THE FEBRILE 












What is the next thing that happened?  











How did (name of child) feel, what happened, or what did (s/he) do did during the rest of this event ?  

















More than 15 minutes 
□ 
 
Don’t know  
□ 
 





IF MORE PRECISE 






How did (name of child) feel, what happened, or what did (s/he) do afterwards?  














How long did (name of child) (feel that way/do that for)? One hour or less 
□ 
 
More than one hour 
□ 
 
Don’t know  
□ 
 















































Don’t know  [GO TO Q3] 
□ 
 












  Q2Fi. What differ(s/ed)?  



















Q3. Has (name of child) ever had two or more of these event s within 







Don’t know  
□ 
 




Q4. How old was (name of child) the first time (s/he) had one of 
these event s? 
 
ENTER IN MONTHS IF CHILD WAS YOUNGER THAN 2 YEARS, YEARS IF 
OLDER. ENTER IN DAYS IF CARER REPORTS THIS EVENT  OCCURRED 








days      □ 
months  □ 
years     □ 
 
Q5. How old was (name of child) the last time (s/he) had one of 




days      □ 
months  □ 










Between 2 and 4 
□ 
 
Between 5 and 10 
□ 
 



















Q7. Has (name of child) ever been prescribed medication to control 





No [GO TO Q8.] 
□ 
 








 Q7A.  
Which medications has (name of child) been prescribed? 
 
RECORD NAMES OF MEDICATIONS HERE 
 
1.   
2.    
3.    
4.    





During the period of life when (name of child) had these event 





No  [GO TO PART 2] 
□ 
 
Don’t know  [GO TO PART 2] 
□ 
 





What would you say is the very first thing that happened when (name of child) had this event ?  











What is the next thing that happened?  










How did (name of child) feel, what happened, or what did (s/he) do did during the rest of this event ?  









How did (name of child) feel, what happened, or what did (s/he) do afterwards?  














Supplementary: Febrile seizure probes 
 
With this event…. 
Did (name of child) vomit or foam at the mouth?  
Did (name of child) wet or soil themselves? 
Was there any twitching of the face, arms or legs? 
•! Both sides, one side?  
 
Did (name of child) lose consciousness?  
Were they sleep or confused afterwards? 
•! How long were they like this more (one hour or more)? 
 
Did they have any weakness of the limbs afterwards?  





Part 2: Other unusual spells 
 
Section A: Description of unusual spells 
 















In the Epilepsy Screen Questionnaire that we sent you, you said that: 
 
LIST ALL OF THE POSITIVE RESPONSES FROM THE EPILEPSY SCREEN (EXCLUDING Q1 FEBRILE SEIZURES) 
 
 
INTERVIEWER READS THE FOLLOWING: 
 
Many people have more than one ‘type’ of unusual spell. What we mean by a ‘different type ‘is that (name of child) feels 
different during the unusual spell, or if what happens before, during or after the unusual spell is different from (his/her) 
other types.  
 
Q1. With this in mind, how many ‘different types’ of unusual spells would you 








Q2. Could you give me a name to use for each type of unusual spells, to make 
it easier to describe each one? Please give me the names in order, from the 














INTERVIEWER READS THE FOLLOWING 




IF MULTIPLE TYPES OF SEIZURE/UNUSUAL SPELL 
Let’s start with the first type: 
Let’s move onto the next type: 
  
 
REPEAT Q1-Q18A AND THE SYMPTOM TABLE FOR EACH TYPE OF UNUSUAL SPELL THE CARER HAS IDENTIFIED 
 
 
Q3.  Please think back to a specific time when (name of child) had one of these (name of spell)s- it could be the first 
time (s/he) had one, the time (s/he) had one most recently, or the time you feel you can describe the best. I would 







What would you say is the very first thing that happened when (name of child) had this (name of spell)?  










What is the next thing that happened?  











How did (name of child) feel, what happened, or what did (s/he) do did during the rest of this (name of 
spell)?  











ASK ONLY IF CARER REPORTS CHILD BEING DIZZY OR LIGHT-HEADED, OTHERWISE GO TO Q3E  
What do you mean by (dizzy/light-headed)? PROBE TO DIFFERENTIATE VERTIGO FROM FEELING LIGHT-


















Q4. How long did the (name of spell) last?  Would you say…  
 
Less than 15 seconds 
□ 
 
15 seconds to 5 minutes 
□ 
 


















During the (name of spell), which of the following best describes 




















During this (name of spell), was (name of child) able to 





















No [ [GO TO Q8] 
□ 
 
Don’t know [ [GO TO Q8] 
□ 
 












Q7A.  For how long was (name of child) tired or confused?   
Would you say… 
 
 
Less than 10 seconds 
□ 
 
10 seconds- 20 minutes 
□ 
 


















Q8. How old was (name of child) the first time (s/he) had this (name 
of spell)   
ENTER IN MONTHS IF CHILD WAS YOUNGER THAN 2 YEARS, YEARS IF 
OLDER. ENTER IN DAYS IF CARER REPORTS THIS UNUSUAL SPELL 
OCCURRED WITHIN THE FIRST MONTH OF LIFE.  CHECK DAYS, 
MONTHS OR YEARS. 
 
 
 days  □ months  □ 
years    □ 
Q9. What month and year was the last time (name of child) had one of these (name of spell)s?   
 
 
                   /                                  
Q10. How old was (name of child) at that time? 
ENTER IN MONTHS IF CHILD WAS YOUNGER THAN 2 YEARS, YEARS IF 
OLDER. ENTER IN DAYS IF CARER REPORTS THIS UNUSUAL SPELL 
OCCURRED WITHIN THE FIRST MONTH OF LIFE.  CHECK DAYS, 




days  □ 
months  □ 
years     □ 
 
Q11. About how many times in (name of child)’s life would you say 
(s/he) experienced these (name of spell)s like the one you just 
described?  Would you say… 
Less than 10 
□ 
 
Between 10 and 100 
□ 
 













IF MORE PRECISE ESTIMATE, NOTE DOWN HERE 
 
Q12. At the time in (name of child)’s life when (s/he) had this type of  
unusual spell most frequently, how often did (s/he) have them?  
Would you say… 
Less than once a month 
□ 
 
1 to 4 times a month  
□ 
 



















Q13. How old was (name of child) at that time? Would you say… 
PROBE FOR BEST ESTIMATE; READ AGE CATEGORIES ONLY 
UP TO CHILD’S CURRENT AGE 
 
<1 year old 
□ 
 
1-5 years old 
□ 
 
6-10 years old 
□ 
 
11-19 years old 
□ 
 






Not applicable  
□ 
 
PROBE FOR PRECISE AGE 
IF KNOWN  
 
 
Q14. Has this (name of spell) occurred whilst (name of child) is awake or asleep? Would you say…. 
Only while (name of child) is asleep [GO TO 
Q16]  
□ 
Mostly while (name of child) is asleep, but not 
always 
□ 
Equally during sleeping and waking 
□ 
Mostly while (name of child) is awake, but not 
always 
□ 
Only while (name of child) is awake 
 
Don’t know [GO TO Q16] 
□ 
 







Q15. Of these (name of spell)s that (name of child) has while (s/he) is awake, when do most of them occur? Would you say… 
 
Within one hour of waking up in the morning or 
after a nap 
□ 
More than 1 hour after waking up but not while 
falling asleep 
□ 









IF MORE PRECISE ESTIMATE, NOTE DOWN HERE 
 
Q16. Does (name of child) ever have a warning or aura that this (name of spell) is about to happen? Yes  
□ 
 
No [GO TO Q17] 
□ 
 
Don’t know [GO TO Q17] 
□ 
 




 Q16A. Could you tell me more about that? 





 Q16.B  Does (name of child) ever experience the 
(warning/aura) you described previously, without it 




No [GO TO Q17] 
□ 
 
Don’t know [GO TO Q17] 
□ 
 




  Q16Bi Could you tell me more about that? 
PROBE TO SPECIFY DETAILS 






Don’t know [GO TO Q18.] 
□ 
 
Not applicable  
□ 
 
 Q17A. What differs? 













Q18. ASK THIS QUESTION ONLY IF CHILD HAD CHANGE IN LEVEL 
OF AWARENESS 
Has (name of child) ever had an (name of spell) with similar 






No [GO TO SYMPTOM TABLE] 
□ 
 
Don’t know [GO TO SYMPTOM TABLE] 
□ 
 




 Q18A. Could you tell me more about that? 












To make sure we get the same information on everyone, now I would like to ask you about specific symptoms that may occur with the (name of spell) 
that we have just spoken about. With this (name of spell): 
Symptom 
 
IF NO, SKIP TO NEXT SYMPTOM 
 
Does this happen 
before, during or 






 Which parts of 
the body are 
involved? 
 PROBE TO SPECIFY 
DETAILS  When they have this, is it… 
Can you tell me more about this? 
 
PROBE TO SPECIFY DETAILS (E.G. 





A. Does (name of child) have 
uncontrollable shaking or 

















Always on the left side 
□ 
 
Always on the right side 
□ 
 
Always on the same side, but 
Don’t know which side 
□ 
 
Sometimes left side, 
sometimes right side 
□ 
 
















B. Does (name of child) have 
sudden and unexpected 
jerking or twitching 
movements of part of 
(his/her) body? 















IF NO OR DON’T KNOW, 


















Always on the left side 
□ 
 
Always on the right side 
□ 
 
Always on the same side, but 
Don’t know which side 
□ 
 
Sometimes left side, 
sometimes right side 
□ 
 















 B1. Has (name of child) 
ever said the jerking 
felt like an electric 





















 B2. Has this type of 
jerking occurred as a 
result of lights shining 
in (name of child)’s 
eyes—for example, 
strobe lights, video 





















C. Does (name of child)’s   
head or other body 
















    
D. Do (name of child’s) eyes 




















E. Does (name of child) bite 
their cheek or the side 















    




















G.  Does (name of child) 
experience any 















    
H. 
Does (name of child) 
experience any change in 




















Does (name of child) have 




















J. Does (name of child) have 
numbness, tingling, pain, 
or other unusual feeling in 

















  Always on the left side 
□ 
 
Always on the right side 
□ 
 
Always on one side, but Don’t 
know which side 
□ 
 
Sometimes left side, 
sometimes right side 
□ 
 














K. Does (name of child) have 
sudden weakness of part of 
(his/her) body, causing 















  Always on the left side 
□ 
 
Always on the right side 
□ 
 
Always on the same side, but 
Don’t know which side 
□ 
 
Sometimes left side, 
sometimes right side 
□ 
 














L. Does (name of child) have 
sudden weakness of 
(his/her) whole body, or 
drop to the ground 
















IF NO OR DON’T KNOW, 
SKIP TO M. 





 L1. Does (name of child) have any jerking 
movements just before 
























 Always on the left side 
□ 
 
Always on the right side 
□ 
 
Always on the same side, but 
Don’t know which side 
□ 
 
Sometimes left side, 
sometimes right side 
□ 
 













 L2. During the weakness or drop attack, which 
of the following best 
describes (name of 
child)’s awareness of 
(his/her) 




























M. Does (name of child) have 
other changes in the way 
(his/her) body feels, such 
as shortness of breath, 
chest tightness, rising 
abdominal sensation, a 
feeling of a wave going 
through their head, a 
feeling that their arms or 
leg are bigger or small then 
they are or feeling hot or 
cold? 



















N. Does (name of child) 
behave in unusual ways 








(his/her) lips, touching 
(his/her) clothes ,making 
cycling movements or 
doing any other repetitive 
or unusual things without 
intending to? 























O. Does (name of child) have 
a brief lapse of awareness 
– lasting 15 seconds or less 
-- without any strange 
















IF NO OR DON’T KNOW, 






 O1. Does this brief lapse 
of awareness occur 



























P. Does (name of child) have 




















Q. Does (name of child) have 
a change in (his/her) 
hearing, or hearing sounds 

























R Does (name of child) have 
a change in (his/her) 




















S. Does (name of child) have 
changes in (his/her) ability 
to speak or understand 
words while still awake 





























T. Does (name of child) have 
sudden unexplained 
changes in (his/her) 
emotional state that 
occurred for no apparent  
reason -- such as fear, 
anxiety, sadness, anger, 
happiness, laughter, or 
other emotions? PROBE TO 
DISTINGUISH REASONABLE 
REACTIONS  FROM PRIMARY 
EMOTIONAL OR PSYCHIC 
AURAS; DO NOT CODE 























U. Does (name of child) have 
déjà vu--that is, a feeling 
that (s/he) has experienced 
something before when it 





















V. Does (name of child) have 
jamais vu - that is, things 
that are familiar to them 
























W. Does (name of child) have 
a feeling that things around 
(him/her) are not real or 
that (s/he) is not real, or an 
























X. Does (name of child) have 
changes in (his/her) 
thoughts such as speeding 
up, (his/her) mind 





















Y. Does (name of child) have  
any other feelings, 









































Section B: Seizure triggers 
Have any of the unusual spells we have discussed been triggered by any of the following stimuli: 
ASK ALL OF A-Q, AND PROBE FOR FURTHER DESCRIPTION OF TRIGGER FOR EACH ‘YES’ RESPONSE 
 
 Yes No Don’t 
know 
Which of (name of 
child’s) unusual spells 
does this trigger? 
Could you tell me more about that?  
PROBE TO SPECIFY DETAILS 
A.  Sounds such as the 
phone ringing, music 
playing, or someone 
speaking? 
     
 
B.  Being startled?       
C.   Any particular 
movements (name of 
child) makes? 
     
D.   Being touched?      
E.  Reading?      
F.  Flashing or blinking 
lights?  
     
G.  Writing or thinking?      
H. Standing up?      
I. Poor sleep?      
J. Stress?      
M. Exercise (e.g. after a 
P.E. lesson)? 
     
N. Missing a meal (e.g. 
missing breakfast, 
lunch or dinner)? 





O. A high fever?      
P. ASK ONLY IF CHILD IS 
OLDER THAN 13 
Alcohol? 
     
















No [GO TO Q5]  
□ 
 
Don’t know [GO TO Q5] 
□ 
 
Not applicable  
□ 
 











How long was the longest unusual spell (name of child) had? 
RECORD LENGTH IN MINUTES   
        minutes 
Q4. 
 
How old was (name of child) when (s/he) had that unusual spell? 




days      □ 
months  □ 











No [GO TO PART 3] 
□ 
 
Don’t know [GO TO PART 3] 
□ 
 




IF YES, PROBE FOR WHICH TYPE OF 
UNUSUAL SPELL 
 
Q6. How old was (name of child) when that happened the first time?  days      □ 
months  □ 
years     □ 
Q7 How many unusual spells did (name of child) have in a row? 
 
 
            seizures 














Q9. Could you tell me more about that?   








Part 3: Further information 
 
ASK THE FOLLOWING QUESTIONS ABOUT PART 1 (FEBRILE SEIZURES) AND PART 2 (OTHER UNUSUAL SPELLS) 
 




Q1. Has (name of child) ever been to a GP because of these unusual 




No  [GO TO Q2]  
□ 
 










PROBE FOR FURTHER 
DETAILS IF NEEDED 
 Q1A. How old was (name of child) when they first saw a GP 
because of these (seizures/unusual spells)? 
 days      □!!!!!!!!!!!!!!
months !□ 




PROBE FOR FURTHER 
DETAILS IF NEEDED 
 Q1B. How many times in the last 12 months has (name of 







PROBE FOR FURTHER 




Q2. Has (name of child) ever seen a specialist because of these 




No [GO TO Q3] 
□ 
 
Don’t know [GO TO Q3] 
□ 
 






PROBE FOR THE TYPE 
OF SPECIALIST (E.G. 
NEUROLOGIST/ 
PAEDIATRICIAN)  
 Q2A. How old was (name of child) when they first saw a 





days!!!   □!!!!!!!!!!!!!!!
months  □ 
years    □ 
Further details 
 
PROBE FOR FURTHER 
DETAILS IF NEEDED 
 Q2B. How many times in the last 12 months has (name of 







PROBE FOR FURTHER 
DETAILS IF NEEDED 
Q3. Has a doctor or specialist ever suggested a potential cause for (name 






















Q4. Has (name of child) ever had their unusual spells investigated, for 
















PROBE FOR WHEN, 
WHERE, RESULT? 





No [GO TO Q7] 
□ 
 
Don’t know [GO TO Q7] 
 
□ 





PROBE FOR FURTHER 





 Q5A. How old was (name of child) when they first started 
taking medications for these unusual spells? 
 
 
days      □!!!!!!!!!!!!!! 
months  □ 
years    □ 
Further details 
 
PROBE FOR FURTHER 
DETAILS IF NEEDED 
 Q5B. Is (name of child) still taking medications for these 
unusual spells now?  















PROBE FOR FURTHER 
DETAILS IF NEEDED 
  Q5Bi
. 
How old was (name of child) when they stopped 
taking the medications? 
 days      □!!!!!!!!!!!!!! 
months  □ 
years    □ 
Further details 
 
PROBE FOR FURTHER 
DETAILS IF NEEDED 
 Q5C. IF STILL TAKING MEDICATIONS Which medications are 
they currently taking now for their unusual spells? 
 
IF NO LONGER TAKING MEDICATIONS 
Which medications did they previously take for their 











Q6. (Does/did) taking this medication reduce the frequency 
















PROBE FOR FURTHER 




Q7. Has (name of child) ever been diagnosed with hypocalcaemia? 
PROMPT “LOW LEVELS OF CALCIUM IN THE BLOOD” IF CARER 






No [GO TO SECTION B] 
□ 
 








PROBE FOR PRECISE 
BLOOD CALCIUM 




Q7A.  How old was (name of child) when they received the 
diagnosis? 
 




days      □!!!!!!!!!!!!!! 
months  □ 
years      □ 
 Q7B. Has a doctor or specialist ever suggested that (name of 





















 Q7C. Did (name of child) continue to have seizures after their 



















Section B: Wrap-up 
 
So that brings us to the end of our questions. 
Q1. Is there anything else that you would like to add? 
  
 





































How are you completing this interview? o! With participant present o! With participant via 
telephone 
 
Child ID:  
 
 
Child DOB:  
Child age:    
Child gender (M/F):  
 
 
Date of interview : ____ ____ /____ ____ /____ ____ ____ ____ 











Section A: Description of Auras. 
I’m!going!to!talk!to!you!about!the!(seizures/unusual!spells)!that!you!have!experienced.!I’d!like!to!check!a!few!things!about!them!with!you,!if!that’s!ok.!
 
Your mother/father told us that 
you:  
!
GIVE SUMMARY OF SEIZURE 
/UNUSUAL SPELL  IDENTIFIED IN 
THE CAREGIVER INTERVIEW!
Q1. 
a)! Can you tell me a little bit more about this (name of spell)? 
 





















Section B: Seizure triggers 
Q3.!Does!anything!seem!to!make!you!have,!or!set!off,!your!(seizures/unusual!spells)?!![AFTER RESPONSE, PROBE]: Anything!else?![IF CHILD IS UNSURE, PROBE]: 
such!as!flashing!or!blinking!lights,!reading!or!being!touched?!!!
! !
! !!
!
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